false Q3 2024 --12-31 0000889348 P1Y 0000889348 2024-01-01 2024-09-30 0000889348 2024-11-12 0000889348 2024-09-30 0000889348 2023-12-31 0000889348 2024-07-01 2024-09-30 0000889348 2023-07-01 2023-09-30 0000889348 2023-01-01 2023-09-30 0000889348 us-gaap:CommonStockMember 2023-12-31 0000889348 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000889348 us-gaap:RetainedEarningsMember 2023-12-31 0000889348 us-gaap:CommonStockMember 2024-03-31 0000889348 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000889348 us-gaap:RetainedEarningsMember 2024-03-31 0000889348 2024-03-31 0000889348 us-gaap:CommonStockMember 2024-06-30 0000889348 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000889348 us-gaap:RetainedEarningsMember 2024-06-30 0000889348 2024-06-30 0000889348 us-gaap:CommonStockMember 2022-12-31 0000889348 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000889348 us-gaap:RetainedEarningsMember 2022-12-31 0000889348 2022-12-31 0000889348 us-gaap:CommonStockMember 2023-03-31 0000889348 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000889348 us-gaap:RetainedEarningsMember 2023-03-31 0000889348 2023-03-31 0000889348 us-gaap:CommonStockMember 2023-06-30 0000889348 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000889348 us-gaap:RetainedEarningsMember 2023-06-30 0000889348 2023-06-30 0000889348 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000889348 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000889348 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000889348 2024-01-01 2024-03-31 0000889348 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0000889348 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0000889348 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000889348 2024-04-01 2024-06-30 0000889348 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0000889348 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0000889348 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0000889348 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000889348 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000889348 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000889348 2023-01-01 2023-03-31 0000889348 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0000889348 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0000889348 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0000889348 2023-04-01 2023-06-30 0000889348 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0000889348 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0000889348 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0000889348 us-gaap:CommonStockMember 2024-09-30 0000889348 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0000889348 us-gaap:RetainedEarningsMember 2024-09-30 0000889348 us-gaap:CommonStockMember 2023-09-30 0000889348 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000889348 us-gaap:RetainedEarningsMember 2023-09-30 0000889348 2023-09-30 0000889348 cvu:GovernmentSubcontractsMember 2024-07-01 2024-09-30 0000889348 cvu:GovernmentSubcontractsMember 2023-07-01 2023-09-30 0000889348 cvu:GovernmentSubcontractsMember 2024-01-01 2024-09-30 0000889348 cvu:GovernmentSubcontractsMember 2023-01-01 2023-09-30 0000889348 cvu:PrimeGovernmentContractsMember 2024-07-01 2024-09-30 0000889348 cvu:PrimeGovernmentContractsMember 2023-07-01 2023-09-30 0000889348 cvu:PrimeGovernmentContractsMember 2024-01-01 2024-09-30 0000889348 cvu:PrimeGovernmentContractsMember 2023-01-01 2023-09-30 0000889348 cvu:CommercialContractsMember 2024-07-01 2024-09-30 0000889348 cvu:CommercialContractsMember 2023-07-01 2023-09-30 0000889348 cvu:CommercialContractsMember 2024-01-01 2024-09-30 0000889348 cvu:CommercialContractsMember 2023-01-01 2023-09-30 0000889348 us-gaap:TransferredOverTimeMember 2024-07-01 2024-09-30 0000889348 us-gaap:TransferredOverTimeMember 2023-07-01 2023-09-30 0000889348 us-gaap:TransferredOverTimeMember 2024-01-01 2024-09-30 0000889348 us-gaap:TransferredOverTimeMember 2023-01-01 2023-09-30 0000889348 us-gaap:TransferredAtPointInTimeMember 2024-07-01 2024-09-30 0000889348 us-gaap:TransferredAtPointInTimeMember 2023-07-01 2023-09-30 0000889348 us-gaap:TransferredAtPointInTimeMember 2024-01-01 2024-09-30 0000889348 us-gaap:TransferredAtPointInTimeMember 2023-01-01 2023-09-30 0000889348 cvu:FavorableAdjustmentMember 2024-01-01 2024-09-30 0000889348 cvu:FavorableAdjustmentMember 2023-01-01 2023-09-30 0000889348 cvu:UnfavorableAdjustmentMember 2024-01-01 2024-09-30 0000889348 cvu:UnfavorableAdjustmentMember 2023-01-01 2023-09-30 0000889348 cvu:PerformanceEquityPlan2009Member 2009-12-31 0000889348 cvu:PerformanceEquityPlan2009Member 2024-09-30 0000889348 cvu:LTIP2016Member 2016-12-31 0000889348 cvu:LTIP2016Member us-gaap:EmployeeStockOptionMember 2016-12-31 0000889348 cvu:LTIP2016Member 2020-10-01 2020-12-31 0000889348 cvu:LTIP2016Member 2020-12-31 0000889348 cvu:LTIP2016Member 2023-04-01 2023-06-30 0000889348 cvu:LTIP2016Member 2023-06-30 0000889348 cvu:LTIP2016Member 2024-09-30 0000889348 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-09-30 0000889348 us-gaap:RestrictedStockMember srt:MaximumMember 2024-01-01 2024-09-30 0000889348 us-gaap:RestrictedStockMember 2024-01-01 2024-09-30 0000889348 us-gaap:PerformanceSharesMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2024-01-01 2024-09-30 0000889348 us-gaap:PerformanceSharesMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2024-01-01 2024-09-30 0000889348 us-gaap:PerformanceSharesMember 2024-01-01 2024-09-30 0000889348 us-gaap:PerformanceSharesMember 2024-09-30 0000889348 us-gaap:CostOfSalesMember 2024-07-01 2024-09-30 0000889348 us-gaap:CostOfSalesMember 2023-07-01 2023-09-30 0000889348 us-gaap:CostOfSalesMember 2024-01-01 2024-09-30 0000889348 us-gaap:CostOfSalesMember 2023-01-01 2023-09-30 0000889348 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-07-01 2024-09-30 0000889348 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-07-01 2023-09-30 0000889348 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-01-01 2024-09-30 0000889348 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-09-30 0000889348 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0000889348 us-gaap:RestrictedStockUnitsRSUMember 2024-09-30 0000889348 us-gaap:RestrictedStockMember 2023-12-31 0000889348 us-gaap:RestrictedStockMember 2024-09-30 0000889348 us-gaap:PerformanceSharesMember 2023-12-31 0000889348 cvu:BankUnitedMember us-gaap:RevolvingCreditFacilityMember 2016-03-24 0000889348 cvu:BankUnitedMember cvu:TermLoanMember 2016-03-24 0000889348 us-gaap:RevolvingCreditFacilityMember cvu:BankUnitedMember 2024-02-19 2024-02-20 0000889348 us-gaap:RevolvingCreditFacilityMember cvu:BankUnitedMember cvu:PeriodOneMember 2024-02-20 0000889348 us-gaap:RevolvingCreditFacilityMember cvu:BankUnitedMember cvu:PeriodTwoMember 2024-02-20 0000889348 us-gaap:RevolvingCreditFacilityMember cvu:BankUnitedMember cvu:PeriodThreeMember 2024-02-20 0000889348 us-gaap:RevolvingCreditFacilityMember cvu:BankUnitedMember cvu:PeriodFourMember 2024-02-20 0000889348 us-gaap:RevolvingCreditFacilityMember cvu:BankUnitedMember cvu:PeriodFiveMember 2024-02-20 0000889348 us-gaap:RevolvingCreditFacilityMember cvu:BankUnitedMember cvu:PeriodSixMember 2024-02-20 0000889348 us-gaap:RevolvingCreditFacilityMember cvu:BankUnitedMember cvu:PeriodSevenMember 2024-02-20 0000889348 us-gaap:RevolvingCreditFacilityMember cvu:BankUnitedMember us-gaap:SubsequentEventMember 2024-11-12 2024-11-13 0000889348 cvu:BankUnitedMember cvu:RevolvingLoanMember 2024-01-01 2024-09-30 0000889348 cvu:BankUnitedMember cvu:RevolvingLoanMember us-gaap:SubsequentEventMember 2024-11-12 2024-11-13 0000889348 us-gaap:RevolvingCreditFacilityMember cvu:BankUnitedMember cvu:PeriodOneMember us-gaap:SubsequentEventMember 2024-11-13 0000889348 us-gaap:RevolvingCreditFacilityMember cvu:BankUnitedMember cvu:PeriodTwoMember us-gaap:SubsequentEventMember 2024-11-13 0000889348 us-gaap:RevolvingCreditFacilityMember cvu:BankUnitedMember cvu:PeriodThreeMember us-gaap:SubsequentEventMember 2024-11-13 0000889348 us-gaap:RevolvingCreditFacilityMember cvu:BankUnitedMember cvu:PeriodFourMember us-gaap:SubsequentEventMember 2024-11-13 0000889348 us-gaap:RevolvingCreditFacilityMember cvu:BankUnitedMember cvu:PeriodFiveMember us-gaap:SubsequentEventMember 2024-11-13 0000889348 us-gaap:RevolvingCreditFacilityMember cvu:BankUnitedMember cvu:PeriodSixMember us-gaap:SubsequentEventMember 2024-11-13 0000889348 us-gaap:RevolvingCreditFacilityMember cvu:BankUnitedMember cvu:PeriodSevenMember us-gaap:SubsequentEventMember 2024-11-13 0000889348 cvu:BankUnitedMember 2024-09-30 0000889348 cvu:BankUnitedMember srt:MinimumMember 2024-01-01 2024-09-30 0000889348 cvu:BankUnitedMember 2024-01-01 2024-09-30 0000889348 cvu:BankUnitedMember cvu:RevolvingLoanMember 2024-09-30 0000889348 cvu:BankUnitedMember us-gaap:RevolvingCreditFacilityMember 2024-09-30 0000889348 cvu:BankUnitedMember us-gaap:RevolvingCreditFacilityMember 2023-12-31 0000889348 cvu:BankUnitedMember 2023-12-31 0000889348 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerOneMember 2024-01-01 2024-09-30 0000889348 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerTwoMember 2024-01-01 2024-09-30 0000889348 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerThreeMember 2024-01-01 2024-09-30 0000889348 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerFourMember 2024-01-01 2024-09-30 0000889348 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerOneMember 2023-01-01 2023-09-30 0000889348 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerTwoMember 2023-01-01 2023-09-30 0000889348 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerThreeMember 2023-01-01 2023-09-30 0000889348 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerFourMember 2023-01-01 2023-09-30 0000889348 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerOneMember 2024-07-01 2024-09-30 0000889348 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerTwoMember 2024-07-01 2024-09-30 0000889348 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerThreeMember 2024-07-01 2024-09-30 0000889348 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerOneMember 2023-07-01 2023-09-30 0000889348 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerTwoMember 2023-07-01 2023-09-30 0000889348 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerThreeMember 2023-07-01 2023-09-30 0000889348 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerFourMember 2023-07-01 2023-09-30 0000889348 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerOneMember 2024-01-01 2024-09-30 0000889348 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerTwoMember 2024-01-01 2024-09-30 0000889348 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerThreeMember 2024-01-01 2024-09-30 0000889348 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerOneMember 2023-01-01 2023-12-31 0000889348 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerTwoMember 2023-01-01 2023-12-31 0000889348 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerThreeMember 2023-01-01 2023-12-31 0000889348 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerFourMember 2023-01-01 2023-12-31 0000889348 cvu:ContractAssetsMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerOneMember 2024-01-01 2024-09-30 0000889348 cvu:ContractAssetsMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerTwoMember 2024-01-01 2024-09-30 0000889348 cvu:ContractAssetsMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerThreeMember 2024-01-01 2024-09-30 0000889348 cvu:ContractAssetsMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerFourMember 2024-01-01 2024-09-30 0000889348 cvu:ContractAssetsMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerOneMember 2023-01-01 2023-12-31 0000889348 cvu:ContractAssetsMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerTwoMember 2023-01-01 2023-12-31 0000889348 cvu:ContractAssetsMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerThreeMember 2023-01-01 2023-12-31 0000889348 cvu:ContractAssetsMember us-gaap:CustomerConcentrationRiskMember cvu:CustomerFourMember 2023-01-01 2023-12-31 0000889348 us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember cvu:VendorOneMember 2024-01-01 2024-09-30 0000889348 2024-06-01 2024-06-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, DC 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  

 

For the quarterly period ended September 30, 2024

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  

 

For the transition period from ___________ to __________

 

Commission File Number: 1-11398

 

 

CPI AEROSTRUCTURES, INC. 

(Exact name of registrant as specified in its charter)

 

New York   11-2520310
(State or other jurisdiction   (IRS Employer Identification Number)
of incorporation or organization)    

 

91 Heartland Blvd., Edgewood, NY   11717
(Address of principal executive offices)   (Zip code)

 

(631) 586-5200 

(Registrant’s telephone number including area code)

 

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading symbol(s) Name of each exchange
on which registered
Common stock, $0.001 par value per share CVU NYSE American

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒  No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer  ☐ Accelerated filer  ☐
Non-accelerated filer  ☒ Smaller reporting company 
  Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No

 

As of November 12, 2024, the registrant had 13,000,670 shares of common stock, $.001 par value, outstanding.

 

 

 

 

 

  INDEX
   
Part I - Financial Information 1
   
Item 1 – Consolidated Financial Statements (Unaudited) 1
   
Condensed Consolidated Balance Sheets as of September 30, 2024 (Unaudited) and December 31, 2023 1
   
Condensed Consolidated Statements of Operations for the Three and Nine months ended September 30, 2024 and 2023 (Unaudited) 2
   
Condensed Consolidated Statements of Shareholders’ Equity for the Three and Nine months ended September 30, 2024 and 2023 (Unaudited) 3
   
Condensed Consolidated Statements of Cash Flows for the Nine months ended September 30, 2024 and 2023 (Unaudited) 4
   
Notes to Condensed Consolidated Financial Statements (Unaudited) 5
   
Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations 12
   
Item 3 – Quantitative and Qualitative Disclosures About Market Risk 18
   
Item 4 – Controls and Procedures 18
   
Part II - Other Information 19
   
Item 1 – Legal Proceedings 19
   
Item 1A – Risk Factors 19
   
Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds 19
   
Item 3 – Defaults Upon Senior Securities 19
   
Item 4 – Mine Safety Disclosures 19
   
Item 5 – Other Information 19
   
Item 6 – Exhibits 19
   
Signatures 20
   

 

 

Part I - Financial Information

 

Item 1 - Consolidated Financial Statements

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

                 
   

September 30,

2024
(Unaudited)

   

December 31, 

2023

 
ASSETS                
Current Assets:                
Cash   $ 1,708,987     $ 5,094,794  
Accounts receivable, net of allowance for credit losses     6,574,853       4,352,196  
Contract assets, net     33,618,971       35,312,068  
Inventory     1,052,286       1,436,647  
Refundable income taxes     40,000       40,000  
Prepaid expenses and other current assets     377,858       678,026  
Total Current Assets     43,372,955       46,913,731  
                 
Operating lease right-of-use assets     3,334,992       4,740,193  
Property and equipment, net     819,078       794,056  
Deferred tax asset     19,425,407       19,938,124  
Goodwill     1,784,254       1,784,254  
Other assets     151,077       189,774  
Total Assets   $ 68,887,763     $ 74,360,132  
                 
LIABILITIES AND SHAREHOLDERS’ EQUITY                
Current Liabilities:                
Accounts payable   $ 14,994,451     $ 10,487,012  
Accrued expenses     5,742,854       10,275,695  
Contract liabilities     1,390,127       5,937,629  
Loss reserve     24,888       337,351  
Current portion of line of credit     2,730,000       2,400,000  
Current portion of long-term debt     31,330       44,498  
Operating lease liabilities, current     2,118,329       1,999,058  
Income taxes payable     28,748       30,107  
Total Current Liabilities     27,060,727       31,511,350  
                 
Line of credit, net of current portion     15,390,000       17,640,000  
Long-term operating lease liabilities     1,494,942       3,100,571  
Long-term debt, net of current portion     2,734       26,483  
Total Liabilities     43,948,403       52,278,404  
                 
Commitments and Contingencies (see note 11)                
                 
Shareholders’ Equity:                
Common stock - $.001 par value; authorized 50,000,000 shares, 12,933,408 and 12,771,434 shares, respectively, issued and outstanding    

12,933

      12,771  
Additional paid-in capital     74,402,288       73,872,679  
Accumulated deficit     (49,475,861 )     (51,803,722 )
Total Shareholders’ Equity     24,939,360       22,081,728  
Total Liabilities and Shareholders’ Equity   $ 68,887,763     $ 74,360,132  

 

See Notes to Condensed Consolidated Financial Statements

 

1

 

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) 

                         
   

For the Three Months Ended 

September 30, 

    For the Nine months Ended
September 30,
 
    2024     2023     2024     2023  
Revenue   $ 19,419,879     $ 20,399,369     $ 59,311,356     $ 62,963,592  
Cost of sales     15,200,210       16,693,279       46,422,514       49,990,986  
Gross profit     4,219,669       3,706,090       12,888,842       12,972,606  
                                 
Selling, general and administrative expenses    

2,742,036

      2,535,065      

8,231,875

      8,210,603  
Income from operations     1,477,633       1,171,025       4,656,967       4,762,003  
                                 
Interest expense     (573,366 )     (663,857 )     (1,793,472 )     (1,816,408 )
Income before provision for income taxes     904,267       507,168       2,863,495       2,945,595  
                                 
Provision for income taxes     154,590       205,804       535,634       503,850  
Net income   $ 749,677     $ 301,364     $ 2,327,861     $ 2,441,745  
                                 
Income per common share, basic   $

0.06

    $ 0.02     $

0.19

    $ 0.19  
                                 
Income per common share, diluted   $

0.06

    $ 0.02     $

0.18

    $ 0.19  
                                 
Shares used in computing income per common share:                                
  Basic     12,647,023       12,759,971       12,559,876       12,613,899  
  Diluted     12,717,128       12,793,133       12,650,340       12,647,061  

 

See Notes to Condensed Consolidated Financial Statements 

 

2

 

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (UNAUDITED)

 

    Common
Stock
Shares
    Common
Stock
Amount
    Additional
Paid-in
Capital
    Accumulated
Deficit
    Total
Shareholders’
Equity
 
Balance at January 1, 2024     12,771,434     $ 12,771     $ 73,872,679     $ (51,803,722 )   $ 22,081,728  
Net income                       168,238       168,238  
Issuance of common stock upon settlement of restricted stock, net     13,334       13                   13  
Stock-based compensation expense                 281,510             281,510  
Balance at March 31, 2024     12,784,768     $ 12,784     $ 74,154,189     $ (51,635,484 )   $ 22,531,489  
Net income                       1,409,946       1,409,946  
Issuance of common stock upon settlement of restricted stock, net     178,095       179                   179  
Stock-based compensation expense                 175,356             175,356  
Balance at June 30, 2024     12,962,863     $ 12,963     $ 74,329,545     $ (50,225,538 )   $ 24,116,970  
Net income                       749,677       749,677  
Issuance of common stock upon settlement of restricted stock, net     (29,455)       (30)                  

(30)

 
Stock-based compensation expense                

72,743

           

72,743

 
Balance at September 30, 2024     12,933,408     $ 12,933     $

74,402,288

    $ (49,475,861 )   $

24,939,360

 
                                         
Balance at January 1, 2023     12,506,795     $ 12,507     $ 73,189,449     $ (69,004,926 )   $ 4,197,030  
Net income                       983,305       983,305  
Issuance of common stock upon settlement of restricted stock, net     19,247       19                   19  
Stock-based compensation expense                 338,904             338,904  
Balance at March 31, 2023     12,526,042     $ 12,526     $ 73,528,353     $ (68,021,621 )   $ 5,519,258  
Net income                       1,157,076       1,157,076  
Issuance of common stock upon settlement of restricted stock, net     201,125       201                   201  
Stock-based compensation expense                 180,015             180,015  
Balance at June 30, 2023     12,727,167     $ 12,727     $ 73,708,368     $ (66,864,545 )   $ 6,856,550  
Net income                       301,364       301,364  
Issuance of common stock upon settlement of restricted stock, net     33,164       34                   34  
Stock-based compensation expense                 140,682             140,682  
Balance at September 30, 2023     12,760,331     $ 12,761     $ 73,849,050     $ (66,563,181 )   $ 7,298,630  

 

See Notes to Condensed Consolidated Financial Statements

 

3

 

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) 

             
    For the Nine months Ended
September 30,
 
    2024     2023  
Cash flows from operating activities:                
Net income   $ 2,327,861     $ 2,441,745  
Adjustments to reconcile net income to net cash (used in) provided by operating activities:                
Depreciation and amortization     305,260       350,974  
Amortization of debt issuance cost     38,697       81,024  
Stock-based compensation     529,771       659,855  
Deferred income taxes     512,717       500,220  
Provision for credit losses     144,565        
Amortization of operating lease right-of-use assets     1,405,201       1,330,209  
Changes in operating assets and liabilities:                
Increase in accounts receivable     (2,367,222 )     (4,266,415 )
Decrease in insurance receivable           3,600,000  
Decrease (increase) in contract assets     1,693,097       (3,646,028 )
Decrease in inventory     384,361       842,196  
Decrease in prepaid expenses and other assets     300,168       305,526  
Increase in accounts payable and accrued expenses     236,130       3,093,351  
(Decrease) increase in contract liabilities     (4,547,502 )     667,615  
Decrease in settlement of litigation obligation           (3,600,000 )
Decrease in operating lease liabilities     (1,486,359 )     (1,320,706 )
Decrease in loss reserve     (312,463 )     (204,916 )
(Decrease) increase in income taxes payable     (1,359 )     5,478  
Net cash (used in) provided by operating activities     (837,077 )     840,128  
                 
Cash flows from investing activities:                
Purchase of property and equipment     (330,282 )     (92,954 )
Net cash used in investing activities     (330,282 )     (92,954 )
                 
Cash flows from financing activities:                
Principal payments on line of credit     (1,920,000 )      
Principal payments on long-term debt     (36,917 )     (1,930,372 )
Repayments of insurance financing obligation     (261,531 )      
Debt issuance costs paid           (54,334 )
Net cash used in financing activities     (2,218,448 )     (1,984,706 )
                 
Net decrease in cash     (3,385,807 )     (1,237,532 )
Cash at beginning of period     5,094,794       3,847,225  
Cash at end of period   $ 1,708,987     $ 2,609,693  
                 
Supplemental disclosures of cash flow information:                
Cash paid during the period for:                
Interest   $ 1,795,495     $ 1,815,939  
Income taxes   $ 36,457     $  

 

See Notes to Condensed Consolidated Financial Statements

 

4

 

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

  1. INTERIM FINANCIAL STATEMENTS

 

Basis of Presentation

 

The Company consists of CPI Aerostructures, Inc. (“CPI Aero”), Welding Metallurgy, Inc. (“WMI”), a wholly owned subsidiary of CPI Aero, and Compac Development Corporation, a wholly owned subsidiary of WMI (collectively, the “Company”, “we”, “us”, or “our”).

 

The condensed consolidated interim financial statements of the Company as of September 30, 2024 and for the three and nine months ended September 30, 2024 and 2023 have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and notes normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to those rules and regulations. The consolidated balance sheet at December 31, 2023 has been derived from audited consolidated financial statements, but does not include all of the information and notes required by U.S. GAAP. The Company believes that the disclosures are adequate to make the information presented not misleading.

 

All adjustments that, in the opinion of the management, are necessary for a fair presentation for the periods presented have been reflected. Such adjustments are of a normal, recurring nature. It is suggested that these consolidated financial statements be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the “Form 10-K”). The results of operations for interim periods are not necessarily indicative of the operating results to be expected for the full year or any other interim period.

 

An operating segment, in part, is a component of an enterprise whose operating results are regularly reviewed by the chief operating decision maker (the “CODM”) to make decisions about resources to be allocated to the segment and assess its performance. Operating segments may be aggregated only to a limited extent. The Company’s CODM, the Chief Executive Officer, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance. The Company has determined that it has a single operating and reportable segment.

 

The Company maintains its cash in multiple financial institutions. The balances are insured by the Federal Deposit Insurance Corporation. From time to time, the Company’s balances may exceed insurance limits. As of September 30, 2024, the Company had $1,476,844 of uninsured balances. The Company limits its credit risk by selecting financial institutions considered to be highly creditworthy.

 

Recently Issued Accounting Standards – Not Adopted

 

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which focuses on the rate reconciliation and income taxes paid. ASU No. 2023-09 requires a public business entity (“PBE”) to disclose, on an annual basis, a tabular rate reconciliation using both percentages and currency amounts, broken out into specified categories with certain reconciling items further broken out by nature and jurisdiction to the extent those items exceed a specified threshold. In addition, all entities are required to disclose income taxes paid, net of refunds received disaggregated by federal, state/local, and foreign and by jurisdiction if the amount is at least 5% of total income tax payments, net of refunds received. For PBEs, the new standard is effective for annual periods beginning after December 15, 2024, with early adoption permitted. An entity may apply the amendments in this ASU prospectively by providing the revised disclosures for the period ending December 31, 2025 and continuing to provide the pre-ASU disclosures for the prior periods, or may apply the amendments retrospectively by providing the revised disclosures for all period presented. We expect this ASU to only impact our disclosures with no impacts to our results of operations, cash flows, and financial condition.

 

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which focuses on a PBE to disclose entity-wide and segment information in the notes to financial statements. This includes the measure of profit or loss that the CODM uses to assess segment performance and decide how to allocate resources, as well as certain specified amounts included in that measure – e.g. revenue, depreciation and amortization, interest and income tax expense. For PBEs, the new standard is effective for annual periods beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. We expect this ASU to only impact our disclosures with no impacts to our results of operations, cash flows, and financial condition.

 

5

 

 

  2. REVENUE

 

Disaggregation of Revenue

 

The following tables present the Company’s revenue disaggregated by contract type and revenue recognition method:

 

    Three months ended
September 30,
    Nine months ended
September 30,
 
    2024     2023     2024     2023  
Government subcontracts   $ 16,986,106     $ 15,375,337     $ 48,951,748     $ 50,550,256  
                                 
Prime government contracts     1,673,483       3,943,723       7,056,711       8,062,682  
Commercial contracts     760,290       1,080,309       3,302,897       4,350,654  
    $ 19,419,879     $ 20,399,369     $ 59,311,356     $ 62,963,592  

 

    Three months ended
September 30,
    Nine months ended
September 30,
 
    2024     2023     2024     2023  
Revenue recognized using over time revenue recognition model   $ 19,092,000     $ 20,053,771     $ 58,558,552     $ 59,353,845  
                                 
Revenue recognized using point in time revenue recognition model     327,879       345,598       752,804       3,609,747  
    $ 19,419,879     $ 20,399,369     $ 59,311,356     $ 62,963,592  

 

Favorable/(Unfavorable) Adjustments to Gross Profit

 

We review our Estimates at Completion (“EAC”) at least quarterly. Due to the nature of the work required to be performed on many of the Company’s performance obligations, the estimation of total revenue and cost at completion is complex, subject to many inputs, and requires significant judgment by management on a contract-by-contract basis. As part of this process, management reviews information including, but not limited to, any outstanding key contract matters, progress towards completion and the related program schedule, identified risks and opportunities, and the related changes in estimates of revenues and costs. The risks and opportunities relate to management’s judgment about the ability and cost to achieve the schedule, consideration of customer-directed delays or reductions in scheduled deliveries, technical requirements, customer activity levels, and related variable consideration. Management must make assumptions and estimates regarding contract revenue and costs, including estimates of labor productivity and availability, the complexity and scope of the work to be performed, the availability and cost of materials including any impact from changing costs or inflation, the length of time to complete the performance obligation, the availability and timing of funding from our customer, and overhead cost rates, among others.

 

Changes in estimates of net sales, cost of sales, and the related impact to operating profit on contracts recognized over time are recognized on a cumulative catch-up basis, which recognizes the cumulative effect of the profit changes on current and prior periods based on a performance obligation’s percentage-of-completion in the current period. A significant change in one or more of these estimates could affect the profitability of one or more of our performance obligations. Our EAC adjustments also include the establishment of, and changes to, loss provisions for our contracts accounted for on a percentage-of-completion basis.

 

Net EAC adjustments had the following impact on our gross profit during the nine months ended September 30, 2024 and 2023:

 

    Nine months ended  
    September 30,
2024
    September 30,
2023
 
Favorable adjustments   $ 1,835,489     $ 2,383,071  
Unfavorable adjustments     (4,059,160 )     (3,396,171 )
Net adjustments   $ (2,223,671 )   $ (1,013,100 )

 

6

 

 

Transaction Price Allocated to Remaining Performance Obligations

 

As of September 30, 2024, the aggregate amount of transaction price allocated to the remaining performance obligations was approximately $91.5 million. This represents the amount of revenue the Company expects to recognize in the future on contracts with unsatisfied or partially satisfied performance obligations as of September 30, 2024.

 

3. CONTRACT ASSETS AND LIABILITIES

 

Contract assets represent revenue recognized on contracts in excess of amounts invoiced to the customers and the Company’s right to consideration is conditional on something other than the passage of time. Amounts may not exceed their net realizable value. Under the typical payment terms of our government as well as military contractor contracts, the customer retains a portion of the contract price until completion of the contract, as a measure of protection for the customer. Our government and military contract or contracts therefore typically result in revenue recognized in excess of billings, which we present as contract assets. Contract assets are classified as current assets. The Company’s contract liabilities represent customer payments received or due from the customer in excess of revenue recognized. Contract liabilities are classified as current liabilities.

 

   

September 30,

2024  

   

December 31,

2023 

 
Contract assets   $ 33,618,971     $ 35,312,068  
Contract liabilities     1,390,127       5,937,629  

 

Revenue recognized for the nine months ended September 30, 2024 and 2023 that was included in the contract liabilities balance as of January 1, 2024 and 2023, respectively, was approximately $5.0 million and $3.0 million, respectively.

 

4. INVENTORY

 

The components of inventory consisted of the following:

 

   

September 30, 

2024 

   

December 31,

2023 

 
Raw materials   $ 440,016     $ 648,264  
Work in progress     103,390       75,795  
Finished goods     508,880       712,588  
Inventory   $ 1,052,286     $ 1,436,647  

  

5. STOCK-BASED COMPENSATION

 

In 2009, the Company adopted the Performance Equity Plan 2009 (the “2009 Plan”). The 2009 Plan reserved 500,000 common shares for issuance. The 2009 Plan provides for the issuance of either incentive stock options or nonqualified stock options to employees, consultants or others who provide services to the Company. The Company has 2,364 shares available for grant under the 2009 Plan as of September 30, 2024.

 

In 2016, the Company adopted the 2016 Long Term Incentive Plan (the “2016 Plan”). The 2016 Plan reserved 600,000 common shares for issuance, provided that no more than 200,000 common shares be granted as incentive stock options. Awards may be made or granted to employees, officers, directors and consultants in the form of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units and other stock-based awards. Any shares of common stock granted in connection with awards other than stock options and stock appreciation rights are counted against the number of shares reserved for issuance under the 2016 Plan as one and one-half shares of common stock for every one share of common stock granted in connection with such award. Any shares of common stock granted in connection with stock options and stock appreciation rights are counted against the number of shares reserved for issuance under the 2016 Plan as one share for every one share of common stock issuable upon the exercise of such stock option or stock appreciation right awarded. In the fourth quarter of 2020, the Company added 800,000 shares to the 2016 Plan, which increased the number of shares reserved for issuance under the 2016 Plan to 1,400,000 shares. In the second quarter of 2023, the Company added an additional 800,000 shares to the 2016 Plan, which increased the number of shares for reserved for issuance under the 2016 Plan to 2,200,000 shares. The Company has 376,094 shares available for grant under the 2016 Plan as of September 30, 2024.

 

Stock-based compensation expense for restricted stock in the consolidated statements of operations is summarized as follows:

                             
    Three months ended
September 30,
    Nine months ended
September 30,
 
    2024     2023     2024     2023  
Cost of sales   $ 14,430     $ 6,612     $ 3,675     $ 58,860  
Selling, general and administrative     58,283       134,104       526,096       600,995  
 Total stock-based compensation expense   $ 72,713     $ 140,716     $ 529,771     $ 659,855  

 

7

 

 

The Company grants restricted stock units (“RSUs”) to its board of directors as partial compensation. These RSUs vest quarterly on a straight-line basis over a one-year period and will fully vest on October 1, 2024.

 

The following table summarizes activity related to outstanding RSUs for the nine months ended September 30, 2024:

 

    RSUs    

Weighted Average  

Grant Date  

Fair Value of  

RSUs 

 
Non-vested – January 1, 2024         $  
Granted     181,323     $ 2.45  
Vested     (135,900 )   $ 2.45  
Forfeited         $  
Non-vested – September 30, 2024     45,423     $ 2.45  

 

The Company grants shares of common stock (“Restricted Stock Awards” or “RSAs”) to select employees. These shares have various vesting dates, ranging from vesting on the grant date to as late as four years from the date of grant. In the event that the employee’s employment is voluntarily terminated prior to certain vesting dates, portions of the shares may be forfeited. At September 30, 2024, the weighted average remaining amortization period was 2.7 years.

 

The following table summarizes activity related to outstanding Restricted Stock Awards for the nine months ended September 30, 2024:

 

   

Restricted 

Stock Awards 

   

Weighted Average   

Grant Date 

Fair Value of  

Restricted
Stock Awards 

 
Non-vested – January 1, 2024     167,071     $ 3.25  
Granted     107,604     $ 2.39  
Vested     (58,587 )   $ 3.18  
Forfeited     (63,213 )   $ 2.78  
Non-vested – September 30, 2024     152,875     $ 2.86  

 

The Company grants shares of common stock (“Performance Restricted Stock Awards” or “PRSAs”) to select officers as part of our long-term incentive program that will result in that number of PRSAs being paid out if the target performance metric is achieved. The award vesting is based on specific performance metrics related to accounts payable delinquency, debt, and net income during the performance period. The PRSAs vest at 0% or 100% and all three metrics must be met to vest at 100%. The PRSAs granted under this program will vest on the fourth anniversary of the grant date, subject to the aforementioned performance criteria. At September 30, 2024, the weighted average remaining amortization period was 2.6 years.

 

The following table summarizes activity related to outstanding PRSAs for the nine months ended September 30, 2024:

 

    PRSAs    

Weighted
Average Grant Date  

Fair Value of  

PRSAs  

 
Non-vested – January 1, 2024     48,050     $ 3.27  
Granted     64,611     $ 2.91  
Vested         $  
Forfeited     (68,585 )   $ 3.12  
Non-vested – September 30, 2024     44,076     $ 2.98  

 

8

 

 

The fair value of all RSUs, PRSAs and RSAs is based on the closing price of our common stock on the grant date. All RSUs, PRSAs, and Restricted Stock Awards vest and settle in common stock (on a one-for-one basis).

 

As of September 30, 2024, unamortized stock-based compensation costs related to restricted share arrangements was $284,780.

 

6. NET INCOME PER SHARE

 

Basic and diluted income per common share is computed using the weighted average number of common shares outstanding. Diluted income per common share is adjusted for the incremental shares attributed to unvested RSUs and RSAs. Incremental shares of 70,105 and 90,463 were used in the calculation of diluted income per common share for the three and nine months ended September 30, 2024, respectively. Incremental shares of 33,162 were used in the calculation of diluted income per common share for both the three and nine months ended September 30, 2023.

 

7. LINE OF CREDIT AND LONG-TERM DEBT

 

On March 24, 2016, the Company entered into the Amended and Restated Credit Agreement with the lenders named therein and BankUnited N.A. as Sole Arranger, Agent and Collateral Agent (as amended from time to time, the “Credit Agreement” or the “BankUnited Facility”). The BankUnited Facility originally provided for a revolving credit loan commitment of $30 million (the “Revolving Loan”) and a $10 million term loan (“Term Loan”). The Revolving Loan bears interest at a rate based upon a pricing grid, as defined in the Credit Agreement. 

 

On February 20, 2024, the Company entered into a Thirteenth Amendment to the Credit Agreement (the “Thirteenth Amendment”). Under the Thirteenth Amendment, the parties amended the Credit Agreement by (a) extending the maturity date of the Company’s existing revolving line of credit to August 31, 2025; and (b) setting the aggregate maximum principal amount of all revolving line of credit loans to $19,800,000 from January 1, 2024 through March 31, 2024, $19,080,000 from April 1, 2024 through June 30, 2024, $18,360,000 from July 1, 2024 through September 30, 2024, $17,640,000 from October 1, 2024 through December 31, 2024, $16,920,000 from January 1, 2025 through March 31, 2025, $16,200,000 from April 1, 2025 through June 30, 2025 and $15,480,000 from July 1, 2025 onward, and for payments to be made by the Company to comply therewith (if any such payments are necessary), on the first day of each such period. 

 

On November 13, 2024, the Company entered into a Fourteenth Amendment to the Credit Agreement (the “Fourteenth Amendment”). Under the Fourteenth Amendment, the parties amended the Credit Agreement by: (i) extending the maturity date of the Company’s existing revolving line of credit (the “Revolving Credit Loans”) to August 31, 2026; (ii) reducing the Base Rate Margin (as defined in the Credit Agreement) from 3.50% to 2.0%; (iii) resetting the aggregate maximum principal amount of all Revolving Credit Loans to $16,890,000 from January 1, 2025 through March 31, 2025, $16,140,000 from April 1, 2025 through June 30, 2025, $15,390,000 from July 1, 2025 through September 30, 2025, $14,640,000 from October 1, 2025 through December 31, 2025, $13,890,000 from January 1, 2026 through March 31, 2026, $13,140,000 from April 1, 2026 through June 30, 2026, and $12,390,000 from July 1, 2026 onward and for payments to be made by the Company to comply therewith (if any such payments are necessary), on the first day of each such period; and (iv) requiring the Company, if it does not deliver to BankUnited, N.A. by December 31, 2025, a commitment letter with banks and terms and conditions reasonably acceptable to the Lenders for refinancing the obligations under the Credit Agreement, to make a payment by January 31, 2026, equal to 2% of the aggregate outstanding principal amount of the Revolving Credit Loans as of December 31, 2025, with 50% of such payment applied to reduce the aggregate outstanding principal and the remaining 50% retained by the Lenders as an amendment fee with respect to the Fourteenth Amendment.

 

The Credit Agreement, as amended, requires us to maintain the following financial covenants: (a) minimum debt service coverage ratio of no less than 1.5 to 1.0 for trailing four fiscal quarter periods; (b) maximum leverage ratio of no less than 4.0 to 1.0 for trailing four fiscal quarter periods; (c) minimum net income after taxes as of the end of each fiscal quarter being no less than $1.00; and (d) a minimum adjusted EBITDA at the end of each fiscal quarter of no less than $1.0 million. The additional principal payments, increase in interest and the Amendment Fee provided for in the Eighth Amendment (entered into on October 28, 2021) and Ninth Amendment to the Credit Agreement (entered into on April 12, 2022) are excluded for purposes of calculating compliance with each of the financial covenants.

 

The BankUnited Facility is secured by all of the Company’s assets. Prior to the Fourteenth Amendment, the Revolving Loan bore interest at the Prime Rate + 3.50%. The Prime Rate was 8.0% as of September 30, 2024 and as such, the Company’s interest rate on the Revolving Loan was 11.5% as of September 30, 2024.

 

As of September 30, 2024 and December 31, 2023, the Company had $18,120,000 and $20,040,000 outstanding under the Revolving Loan, respectively. $2,730,000 of the Revolving Loan is payable by September 30, 2025 and the remaining balance of $15,390,000 of the revolving line of credit matures and is payable by August 31, 2026, as amended November 13, 2024. 

 

9

 

 

The Company has cumulatively paid approximately $962,000 of total debt issuance costs in connection with the BankUnited Facility, of which approximately $43,000 and $82,000 is unamortized and is included in other assets at September 30, 2024 and December 31, 2023, respectively. 

 

Also included in long-term debt are financing leases of $34,064 and $70,981 at September 30, 2024 and December 31, 2023, respectively, including a current portion of $31,330 and $44,498, respectively. The maturities of the September 30, 2024 balance of these financing leases are as follows:

 

For the Year Ending December 31,    
Remainder of 2024   $ 7,581  
2025     26,483  
Total                      $ 34,064  

 

8. MAJOR CUSTOMERS AND VENDORS
   

During the nine months ended September 30, 2024, our four largest customers accounted for 35%, 24%, 12%, and 12% of revenue. During the nine months ended September 30, 2023, our four largest customers accounted for 31%, 26%, 12% and 10% of revenue. During the three months ended September 30, 2024, our three largest customers accounted for 40%, 23% and 11% of revenue. During the three months ended September 30, 2023, our four largest customers accounted for 28%, 21%, 19% and 13% of revenue.

 

At September 30, 2024, 38%, 25%, and 13% of our accounts receivable were from three of our largest customers. At December 31, 2023, 30%, 17%, 12%, and 11% of accounts receivable were due from our four largest customers. 

 

At September 30, 2024, 27%, 26%, 15% and 12% of our contract assets were from four of our largest customers. At December 31, 2023, 26%, 23%, 18%, and 15% of our contract assets were related to our four largest customers.

 

At September 30, 2024, 10% of our accounts payable was from one of our largest vendors. At December 31, 2023 no vendors accounted for 10% of our accounts payable.

 

 9. LEASES

 

The Company leases manufacturing and office space under an agreement classified as an operating lease. On November 10, 2021, the Company executed the second amendment to the lease agreement for its manufacturing and office space, which extends the lease agreement’s expiration date to April 30, 2026. The lease agreement does not include any renewal options. The agreement provides for an initial monthly base amount plus annual escalations through the term of the lease. In addition to the monthly base amounts in the lease agreement, the Company is required to pay real estate taxes and operating expenses during the lease terms.

 

The Company also leases office equipment in agreements classified as operating leases.  

 

For the nine months ended September 30, 2024 and 2023, the Company’s operating lease expense was $1,611,487 and $1,612,713, respectively. For the three months ended September 30, 2024 and 2023, the Company’s operating lease expense was $528,127 and $529,624, respectively.

 

Future minimum lease payments under non-cancellable operating leases as of September 30, 2024 were as follows:

 

For the Year Ending December 31,        
Remainder of 2024     $ 560,249  
2025       2,283,354  
2026       850,276  
2027       111,065  
2028       9,228  
Total undiscounted operating lease payments       3,814,172  
Less imputed interest       (200,901 )
Present value of operating lease payments     $ 3,613,271  

 

The following table sets forth the right-of-use assets and operating lease liabilities as of: 

 

    September 30,
2024
    December 31,
2023
 
Assets                
Right-of-use assets, net   $ 3,334,992     $ 4,740,193  
                 
Liabilities                
Current operating lease liabilities   $ 2,118,329     $ 1,999,058  
Long-term operating lease liabilities     1,494,942       3,100,571  
Total lease liabilities   $ 3,613,271     $ 5,099,629  

 

10

 

 

The Company’s weighted average remaining lease term for its operating leases is 1.7 years as of September 30, 2024. The Company’s weighted average discount rate for its operating leases is 5.5% as of September 30, 2024.

 

10. INCOME TAXES

 

Income taxes are accounted for under the asset and liability method whereby deferred tax assets and liabilities are recognized for future tax consequences attributable to the temporary differences between the consolidated financial statements carrying amounts of assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company’s policy is to record estimated interest and penalties related to uncertain tax positions in income tax expense. 

 

The provision for income tax for the three months ended September 30, 2024 and 2023 was $154,590 and $205,804, respectively. The provision for income tax for the nine months ended September 30, 2024 and 2023 was $535,634 and $503,850, respectively.

 

The effective income tax rate for the nine months ended September 30, 2024 is 18.7 %. The difference between the effective income tax rate for the nine months ended September 30, 2024 and the statutory income tax rate of 21.0% for the nine months ended September 30, 2024 is due primarily to the estimated R&D credit, state income taxes and permanent tax differences. The effective income tax rate for the nine months ended September 30, 2023 was 17.1%. The difference between the effective income tax rate for the nine months ended September 30, 2023 and the statutory income tax rate of 21% for the nine months ended September 30, 2023 was due to the estimated R&D credit, the partial release of approximately $122,500 of the Company’s valuation allowance on its deferred tax asset recorded during the nine months ending September 30, 2023, state income taxes and permanent tax differences.

 

11. COMMITMENTS AND CONTINGENCIES

 

The Company may be involved in various claims, suits, assessments, investigations, and legal proceedings that arise from time to time in the ordinary course of its business. The Company accrues a liability when it is both probable a liability has been incurred and the amount of the loss can be reasonably estimated. The Company reviews these accruals at least quarterly and adjusts them to reflect ongoing negotiations, settlements, rulings, advice of legal counsel, and other relevant information. To the extent new information is obtained and the Company’s views on the probable outcomes of claims, suits, assessments, investigations, or legal proceedings change, changes in the Company’s accrued liabilities would be recorded in the period such determination is made. For some matters, the amount of liability is not probable or the amount cannot be reasonably estimated and, therefore, accruals have not been made.

 

The Company reached a settlement with the SEC on June 20, 2024 related to the Company’s previously announced and filed restatements of certain of its financial statements for fiscal periods between January 1, 2018 and December 31, 2022. Under the terms of this settlement, if the Company fails to comply with various undertakings, a civil monetary penalty in the amount of $400,000 will be due to the SEC by June 30, 2025 (the “Undertakings”). The Undertakings are as follows: (a) the Company shall fully remediate its outstanding material weaknesses in Internal Controls over Financial Reporting (“ICFR”) and have effective ICFR and disclosure controls and procedures (“DCP”) by December 31, 2024; (b) the Company shall publicly disclose, concurrent with the filing of the 2024 Form 10-K, whether in management’s opinion, the Company has fully remediated its material weaknesses in ICFR and has effective ICFR and DCP; and (c) the Company shall certify, in writing, compliance with the undertaking(s) set forth above. The certification shall be made by the Company’s CEO and identify the undertaking(s), provide written evidence of compliance in the form of a narrative, and be supported by exhibits sufficient to demonstrate compliance. The certification and supporting material shall be submitted to the SEC no later than sixty (60) days from the date of the completion of the undertakings.

 

11

 

 

Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations 

 

The following discussion should be read in conjunction with the Company’s consolidated financial statements and notes thereto contained in this report.

 

Forward Looking Statements

 

When used in this Form 10-Q and in future filings by us with the Securities and Exchange Commission (the “SEC”), the words or phrases “will likely result,” “management expects” or “we expect,” “will continue,” “is anticipated,” “estimated” or similar expressions are intended to identify “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical earnings and those presently anticipated or projected. The risks are included in Part I, Item 1A – Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2023 (the “Form 10-K”). We have no obligation to publicly release the result of any revisions which may be made to any forward-looking statements to reflect anticipated or unanticipated events or circumstances occurring after the date of such statements.

 

Business Operations

 

We are engaged in the contract production of structural aircraft parts for fixed wing aircraft and helicopters in both the commercial and defense markets. We also have a strong and growing presence in the aerosystems sector of the market, with our production of various reconnaissance pod structures and fuel panel systems. Within the global aerostructure and aerosystem supply chain, we are either a Tier 1 supplier to aircraft original equipment manufacturers (“OEMs”) or a Tier 2 subcontractor to major Tier 1 manufacturers. We also are a prime contractor to the United States Department of Defense (“DOD”), primarily the United States Air Force (“USAF”). In conjunction with our assembly operations, we provide engineering, program management, supply chain management and kitting, and maintenance, repair and overhaul (“MRO”) services.

 

Recent Developments

 

None.

 

Backlog

 

We produce custom assemblies pursuant to long-term contracts and customer purchase orders. Funded backlog consists of aggregate funded values under such contracts and purchase orders, excluding the portion previously included in operating revenues pursuant to Accounting Standards Codification Topic 606 (“ASC 606”). Unfunded backlog is the estimated amount of future orders under the expected duration of the programs. Substantially all of our backlog is subject to termination at will and rescheduling, without significant penalty. Funds are often appropriated for programs or contracts on a yearly or quarterly basis, even though the contract may call for performance that is expected to take a number of years. Therefore, our funded backlog does not include the full value of our contracts.

 

Our total backlog as of September 30, 2024 and December 31, 2023 is shown below.

 

Backlog
(Total)
  September 30,
2024
    December 31,
2023
 
Funded   $ 91,502,000     $ 118,218,000  
Unfunded     414,519,000       395,133,000  
Total   $ 506,021,000     $ 513,351,000  

 

Approximately 96% of the total amount of our backlog at September 30, 2024 was attributable to government and military contractor contracts. Our backlog attributable to government contracts at September 30, 2024 and December 31, 2023 was as follows:

 

Backlog
(Government)
  September 30,
2024
    December 31,
2023
 
Funded   $ 87,528,000     $ 115,681,000  
Unfunded     398,319,000       383,574,000  
Total   $ 485,847,000     $ 499,255,000  

 

12

 

 

Our backlog attributable to commercial contracts at September 30, 2024 and December 31, 2023 was as follows:

 

Backlog
(Commercial)
    September 30,
2024
      December 31,
2023
 
Funded   $ 3,974,000     $ 2,537,000  
Unfunded     16,200,000       11,559,000  
Total   $ 20,174,000     $ 14,096,000  

 

The total backlog at September 30, 2024 is primarily comprised of long-term programs with Raytheon (Next Generation Jammer-Mid Band Pods and Advanced Tactical Pods), Lockheed Martin (F-16 RI/DCC’s), Raytheon (B-52 Radar Racks), USAF (T-38 Classic Structural Modification Kits), Sikorsky (UH-60 BLACKHAWK Gunner Windows and CH-53K Welded Tubes), Raytheon (Airborne Reconnaissance Pods), Embraer (Phenom 300 Engine Inlets), and L3Harris (Next Generation Jammer-Low Band Pods (“NGJ-LB”) .

 

The funded backlog at September 30, 2024 is primarily from purchase orders under long-term contracts with Raytheon (NGJ – Mid Band Pods and Advanced Tactical Pods), USAF (T-38 Classic Structural Modification Kits), Sikorsky (CH-53K Welded Tubes), Sikorsky (UH-60 BLACKHAWK Gunner Windows), Raytheon (Airborne Reconnaissance Pods), Boeing (A-10 Main Landing Gear Pods), Lockheed Martin (F-16 RI/DCC’s), Embraer (Phenom 300 Engine Inlets) and L3Harris (NGJ-Low Band Pods).

 

Critical Accounting Estimates

 

We make a number of significant estimates, assumptions and judgments in the preparation of our financial statements. See Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Form 10-K, for a discussion of our critical accounting estimates. There have been no significant changes to the application of our critical accounting estimates during the quarter ended September 30, 2024.

 

Results of Operations

 

Revenue

 

Total Revenue for the three months ended September 30, 2024 was $19,419,879 compared to $20,399,369 for the same period last year, a decrease of $979,490 or 4.8%, driven primarily by decreases in our USAF T-38 Pacer Classic Structure Modification Kits program and Northrop Grumman E-2D Advanced Hawkeye Outer Wing Panels (“OWP”), partly offset by increases in our Raytheon NGJ – Mid Band Pods.

 

Total Revenue for the nine months ended September 30, 2024 was $59,311,356 compared to $62,963,592 for the same period last year, a decrease of $3,652,236 or 5.8%, driven primarily by decreases in our Sikorsky UH-60 BLACKHAWK Hover Infrared Suppression System (“HIRSS”) Module Assemblies program, Northrop Grumman E-2D Advanced Hawkeye OWP program and Lockheed Martin F-16 Rudder Island program, partly offset by increases in our Raytheon NGJ – Mid Band Pods program, and Collins MS-110 program.

 

Revenue from military subcontracts was $16,986,106 for the three months ended September 30, 2024 compared to $15,375,337 for the three months ended September 30, 2023, an increase of $1,610,769 or 10.5%, driven primarily by increases in our Raytheon NGJ – Mid Band Pods program partly offset by decreases in our Lockheed Martin F-16 Rudder Island program.

 

Revenue from military subcontracts was $48,951,748 for the nine months ended September 30, 2024 compared to $50,550,256 for the nine months ended September 30, 2023, a decrease of $1,598,508 or 3.2%, driven primarily by decreases in our Sikorsky UH-60 BLACKHAWK HIRSS Module Assemblies program partly offset by increases in our Raytheon NGJ – Mid Band Pods program.

 

Revenue from government military contracts was $1,673,483 for the three months ended September 30, 2024 compared to $3,943,723 for the three months ended September 30, 2023, a decrease of $2,270,240 or 57.6%, driven primarily by a decrease in our USAF T-38 Pacer Classic Structural Modification Kits program due to push out of customer inductions of aircraft.

 

Revenue from government military contracts was $7,056,711 for the nine months ended September 30, 2024 compared to $8,062,682 for the nine months ended September 30, 2023, a decrease of $1,005,971 or 12.5%, driven primarily by decreases in our USAF T-38 Pacer Classic Structural Modification Kits program and DLA F-16 Wing Skins program.

 

Revenue from commercial subcontracts was $760,290 for the three months ended September 30, 2024 compared to $1,080,309 for the three months ended September 30, 2023, a decrease of $320,019 or 29.6%, primarily on a decrease in our Embraer Phenom-300 Engine Inlet Assemblies program.

 

Revenue from commercial subcontracts was $3,302,897 for the nine months ended September 30, 2024 compared to $4,350,654 for the nine months ended September 30, 2023, a decrease of $1,047,757 or 24.1%, primarily on a decrease in our Embraer Phenom-300 Engine Inlet Assemblies program.

 

13

 

 

Cost of Sales

 

Total Cost of Sales for the three months ended September 30, 2024 and 2023 was $15,200,210, and $16,693,279, respectively, a decrease of $1,493,069 or 9%.

 

Total Cost of Sales for the nine months ended September 30, 2024 and 2023 was $46,422,514 and $49,990,986, respectively, a decrease of $3,568,472 or 7%.

 

The components of the cost of sales were as follows:

 

    Three months ended     Nine months ended  
    September 30,
2024
    September 30,
2023
    September 30,
2024
    September 30,
2023
 
Procurement   $ 9,219,097     $ 10,815,261     $ 28,702,158     $ 31,774,115  
Labor     1,861,505       1,580,290       5,460,235       5,302,436  
Factory overhead     4,021,411       4,036,825       12,058,902       12,083,270  
                                 
Other cost of sales     98,197       260,903       201,219       831,165  
Cost of sales   $ 15,200,210     $ 16,693,279     $ 46,422,514     $ 49,990,986  

 

Procurement for the three months ended September 30, 2024 was $9,219,097 compared to $10,815,261 for the three months ended September 30, 2023, a decrease of $1,596,164 or 14.8%, driven primarily by lower procurement for our USAF T-38 Pacer Classic Structural Modification Kits program due to push out of customer inductions of aircraft and Northrop Grumman E-2D Advanced Hawkeye OWP program.

 

Procurement for the nine months ended September 30, 2024 was $28,702,158 compared to $31,774,115 for the nine months ended September 30, 2023, a decrease of $3,071,957 or 9.7%, driven primarily by lower procurement in our Sikorsky UH-60 BLACKHAWK HIRSS Module Assemblies program and USAF T-38 Pacer Classic Structural Modification Kits program partially offset by higher procurement in our Raytheon NGJ – Mid Band Pods program.

 

Labor costs for the three months ended September 30, 2024 were $1,861,505 compared to $1,580,290 for the three months ended September 30, 2023, an increase of $281,215 or 17.8% primarily driven by increases in work performed in the Boeing A-10 program, Sikorsky “CH-53K” Tube Assembly, and the Raytheon NGJ – Mid Band Pods program.

 

Labor costs for the nine months ended September 30, 2024 were $5,460,235 compared to $5,302,436 for the nine months ended September 30, 2023, an increase of $157,799 or 3.0% primarily driven by an increase in work performed on the Lockheed Martin F-16 Rudder Island.

 

Factory overhead for the three months ended September 30, 2024 was $4,021,411 compared to $4,036,825 for the three months ended September 30, 2023, a decrease of $15,414 or 0.4%.

 

Factory overhead for the nine months ended September 30, 2024 was $12,058,902 compared to $12,083,270 for the nine months ended September 30, 2023, a decrease of $24,368 or 0.2%.

 

Other cost of sales relates to items that can increase or decrease cost of sales such as changes in inventory reserves, changes in loss contract provisions, absorption variances and direct charges to cost of sales. Other cost of sales for the three months ended September 30, 2024 was $98,197 compared to a $260,903 for the three months ended September 30, 2023, a decrease of $162,706 or 62.4%. The decrease is primarily the result of lower loss reserve required during the three months ended September 30, 2024 as compared to the three months ended September 30, 2023.

 

Other cost of sales for the nine months ended September 30, 2024 was $201,219 compared to $831,165 for the nine months ended September 30, 2023, a decrease in cost of $629,946 or 75.8%. The decrease is primarily the result of a lower required loss reserve and lower level of direct charges to cost of sales during the nine months ended September 30, 2024 as compared to the nine months ended September 30, 2023.

 

14

 

 

Gross Profit

 

Gross profit and gross profit percentage (“gross margin”) for the three months ended September 30, 2024 was $4,219,669 and 21.7%, respectively, compared to $3,706,090 and 18.2%, respectively, for the three months ended September 30, 2023, an increase of $513,579, or 13.9%, and 350 basis points, respectively, for the reasons noted above and a favorable year-over-year mix.

 

Gross profit and gross profit percentage (“gross margin”) for the nine months ended September 30, 2024 was $12,888,842 and 21.7%, respectively, compared to $12,972,606 and 20.6%, respectively, for the nine months ended September 30, 2023, a decrease of $83,764, or 0.6%, and 110 basis points, respectively, for the reasons noted above.

 

Favorable/Unfavorable Adjustments to Gross Profit

 

During the nine months ended September 30, 2024 and 2023, circumstances required that we make changes in estimates to various contracts. Such changes in estimates resulted in changes in total gross profit as follows:

 

    Nine months ended  
    September 30,
2024
    September 30,
2023
 
Favorable adjustments   $ 1,835,489     $ 2,383,071  
Unfavorable adjustments     (4,059,160 )     (3,396,171 )
Net adjustments   $ (2,223,671 )   $ (1,013,100 )

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses for the three months ended September 30, 2024 were $2,742,036 compared to $2,535,065 for the three months ended September 30, 2023, an increase of $206,971 or 8.2%. The increase was primarily the result of higher personnel related expenses.

 

Selling, general and administrative expenses for the nine months ended September 30, 2024 were $8,231,875 compared to $8,210,603 for the nine months ended September 30, 2023, an increase of $21,272 or 0.3%.

 

Interest expense

 

Interest expense for the three months ended September 30, 2024 was $573,366, compared to $663,857 for the three months ended September 30, 2023, a decrease of $90,491 or 13.6%. The decrease was the result of lower year-over-year interest rates charged on our outstanding debt under the Credit Agreement, combined with a year-over-year decrease in the amount of our outstanding debt under the Credit Agreement.

 

Interest expense for the nine months ended September 30, 2024 was $1,793,472, compared to $1,816,408 for the nine months ended September 30, 2023, a decrease of $22,936 or 1.3%.

 

Income Before Provision for Income Taxes

 

Income before provision for income taxes for the three months ended September 30, 2024 was $904,267 compared to $507,168 for the three months ended September 30, 2023, an increase of $397,099 or 78.3% for the reasons noted above.

 

Income before provision for income taxes for the nine months ended September 30, 2024 was $2,863,495 compared to $2,945,595 for the nine months ended September 30, 2023, a decrease of $82,100 or 2.8% for the reasons noted above.

 

Provision for Income Taxes

 

Provision for income taxes for the three months ended September 30, 2024 was $154,590 compared to $205,804 for the three months ended September 30, 2023, a decrease of $51,214, or 24.9%. The decrease in the provision for income tax is primarily the result of the annualization of the September 30, 2023 tax rate.

 

The effective income tax rate for the three months ended September 30, 2024 is 17.1%. The difference between the effective income tax rate for the three months ended September 30, 2024 and the statutory income tax rate of 21% for the three months ended September 30, 2024 is primarily due to estimated R&D credit, state income taxes and permanent tax differences.

 

15

 

 

Provision for income taxes for the nine months ended September 30, 2024 was $535,634 compared to $503,850 for the nine months ended September 30, 2023, an increase of $31,784, or 6.3%. The increase in the provision for income tax is primarily the result of the reduced impact in the rate for the R&D benefit.

 

The effective income tax rate for the nine months ended September 30, 2024 is 18.7%. The difference between the effective income tax rate for the nine months ended September 30, 2024 and the statutory income tax rate of 21% for the nine months ended September 30, 2024 is primarily due to estimated R&D credit, state income taxes and permanent tax differences.

 

Net Income and Earnings per Share

 

Net income for the three months ended September 30, 2024 was $749,677 compared to $301,364 for the three months ended September 30, 2023, an increase of $448,313 or 148.8%% for the reasons noted above.

 

Basic and diluted income per share for the three months ended September 30, 2024 of $0.06 compared to $0.02 for the three months ended September 30, 2023, an increase of $0.04, or 200%.

 

Basic and diluted income per share for the three months ended September 30, 2024 was calculated using 12,647,023 and 12,717,128 weighted average basic and diluted shares outstanding, respectively, as compared to 12,759,971 and 12,793,133 weighted average basic and diluted shares outstanding, respectively, for the three months ended September 30, 2023.

 

Net income for the nine months ended September 30, 2024 was $2,327,861 compared to $2,441,745 for the nine months ended September 30, 2023, a decrease of $113,884 or 4.7% for the reasons noted above.

 

Basic income per share for the nine months ended September 30, 2024 of $0.19 was consistent with $0.19 for the nine months ended September 30, 2023. Diluted income per share for the nine months ended September 30, 2024 of $0.18 compared to $0.19 for the nine months ended September 30, 2023, a decrease of $0.01, or 5.3%.

 

Basic and diluted income per share for the nine months ended September 30, 2024 was calculated using 12,559,876 and 12,650,340 weighted average basic and diluted shares outstanding, respectively, as compared to 12,613,899 and 12,647,061 weighted average basic and diluted shares outstanding, respectively, for the nine months ended September 30, 2023.

 

Liquidity and Capital Resources

 

General

 

At September 30, 2024, we had working capital of $16,312,228 compared to $15,402,381 at December 31, 2023, an increase of $909,847 or 5.9%. The increase was driven primarily by lower contract liabilities and higher accounts receivable, partly offset by lower cash and contract assets, lower inventory and lower prepaid expenses and other current assets.

 

Cash Flow

 

A large portion of our cash flow is used to pay for materials and processing costs associated with contracts that are in process and which do not provide for progress payments. Costs and related earnings for which we do not bill on a progress basis, and which, as a result, we bill upon shipment of products, are components of contract assets on our consolidated balance sheets and represent the aggregate costs and related earnings for uncompleted contracts for which the customer has not yet been billed. These costs and earnings are recovered upon shipment of products and presentation of billings in accordance with contract terms.

 

Because ASC 606 requires us to use estimates in determining revenue, costs and profits and in assigning the amounts to accounting periods, there can be a significant disparity between earnings (both for accounting and tax purposes) as reported and actual cash that we receive during any reporting period. Accordingly, it is possible that we may have a shortfall in our cash flow and may need to borrow money or take steps to defer cash outflows until the reported earnings materialize into actual cash receipts.

 

Some of our programs require us to expend up-front costs that may have to be amortized over a portion of production units. In the case of significant program delays and/or program cancellations, we could experience margin degradation, which may be material for costs that are not recoverable. Such charges and the loss of up-front costs could have a material impact on our liquidity and results of operations.

 

We continuously work to improve our payment terms from our customers, including accelerated progress payment arrangements, as well as exploring alternate funding sources.

 

16

 

 

At September 30, 2024, we had cash of $1,708,987 compared to $5,094,794 at December 31, 2023, a decrease of $3,385,807 or 66.5%. This decrease was primarily the result of cash flow used in operating activities and repayment of debt.

 

Bank Credit Facilities

 

On March 24, 2016, the Company entered into an Amended and Restated Credit Agreement with the lenders named therein and BankUnited N.A. as Sole Arranger, Agent and Collateral Agent (as amended from time to time, the “Credit Agreement” or the “BankUnited Facility”). The Credit Agreement originally provided for a revolving credit loan commitment of $30 million (the “Revolving Loan”) and a $10 million term loan (“Term Loan”). The Revolving Loan bears interest at a rate as defined in the Credit Agreement.

 

On February 20, 2024, the Company entered into a Thirteenth Amendment to the Credit Agreement (the “Thirteenth Amendment”). Under the Thirteenth Amendment, the parties amended the Credit Agreement by (a) extending the maturity date of the Company’s existing revolving line of credit to August 31, 2025; and (b) setting the aggregate maximum principal amount of all revolving line of credit loans to $19,800,000 from January 1, 2024 through March 31, 2024, $19,080,000 from April 1, 2024 through June 30, 2024, $18,360,000 from July 1, 2024 through September 30, 2024, $17,640,000 from October 1, 2024 through December 31, 2024, $16,920,000 from January 1, 2025 through March 31, 2025, $16,200,000 from April 1, 2025 through June 30, 2025 and $15,480,000 from July 1, 2025 onward, and for payments to be made by the Company to comply therewith (if any such payments are necessary), on the first day of each such period.

 

On November 13, 2024, the Company entered into a Fourteenth Amendment to the Credit Agreement (the “Fourteenth Amendment”). Under the Fourteenth Amendment, the parties amended the Credit Agreement by: (i) extending the maturity date of the Company’s existing revolving line of credit (the “Revolving Credit Loans”) to August 31, 2026; (ii) reducing the Base Rate Margin (as defined in the Credit Agreement) from 3.50% to 2.0%; (iii) resetting the aggregate maximum principal amount of all Revolving Credit Loans to $16,890,000 from January 1, 2025 through March 31, 2025, $16,140,000 from April 1, 2025 through June 30, 2025, $15,390,000 from July 1, 2025 through September 30, 2025, $14,640,000 from October 1, 2025 through December 31, 2025, $13,890,000 from January 1, 2026 through March 31, 2026, $13,140,000 from April 1, 2026 through June 30, 2026, and $12,390,000 from July 1, 2026 onward and for payments to be made by the Company to comply therewith (if any such payments are necessary), on the first day of each such period; and (iv) requiring the Company, if it does not deliver to BankUnited, N.A. by December 31, 2025, a commitment letter with banks and terms and conditions reasonably acceptable to the Lenders for refinancing the obligations under the Credit Agreement, to make a payment by January 31, 2026, equal to 2% of the aggregate outstanding principal amount of the Revolving Credit Loans as of December 31, 2025, with 50% of such payment applied to reduce the aggregate outstanding principal and the remaining 50% retained by the Lenders as an amendment fee with respect to the Fourteenth Amendment.

 

The Credit Agreement, as amended, requires us to maintain the following financial covenants: (a) minimum debt service coverage ratio of no less than 1.5 to 1.0 for trailing four fiscal quarter periods; (b) maximum leverage ratio of no less than 4.0 to 1.0 for trailing four fiscal quarter periods; (c) minimum net income after taxes as of the end of each fiscal quarter being no less than $1.00; and (d) a minimum adjusted EBITDA at the end of each fiscal quarter of no less than $1.0 million. The additional principal payments, increase in interest and the Amendment Fee provided for in the Eighth Amendment (entered into on October 28, 2021) and Ninth Amendment to the Credit Agreement (entered into on April 12, 2022) are excluded for purposes of calculating compliance with each of the financial covenants.

 

The BankUnited Facility is secured by all of the Company’s assets. Prior to the Fourteenth Amendment the Revolving Loan bore interest at the Prime Rate + 3.50%. The Prime Rate was 8.0% as of September 30, 2024 and as such, the Company’s interest rate on the Revolving Loan was 11.5% as of September 30, 2024.

 

As of September 30, 2024 and December 31, 2023, the Company had $18,120,000 and $20,040,000 outstanding under the Revolving Loan, respectively.

 

There is currently no availability for borrowings under the Revolving Loan and the Company finances its operations from internally generated cash flow.

 

Liquidity

 

We believe that our existing resources as of September 30, 2024 will be sufficient to meet our current working capital needs for at least the next 12 months from the date of issuance of our consolidated financial statements. However, our working capital requirements can vary significantly, depending in part on the timing of new program awards and the payment terms with our customers and suppliers. If our working capital needs exceed our cash flows from operations, we would look to our cash balances and availability for borrowings under our borrowing arrangement to satisfy those needs, as well as potential sources of additional capital, which may not be available on satisfactory terms and in adequate amounts, if at all.

 

17

 

 

Contractual Obligations

 

For information concerning our contractual obligations, see Contractual Obligations under Item 7 of Management’s Discussion and Analysis of Financial Condition and Results of Operations of the Form 10-K.

 

Inflation

 

Inflation historically has not had a material effect on our operations, although the current inflationary environment in the U.S., and its impact on interest rates, the supply chain, the labor market and general economic conditions, are factors that the Company actively monitors in an attempt to mitigate and manage potential negative impacts on and risks faced by the Company. The majority of the Company’s long term contracts with its customers reflect fixed pricing and its long term contracts with its suppliers reflect fixed pricing. When bidding for work, the Company takes inflation risk and supply side pricing risk into account in its proposals.

 

Item 3 – Quantitative and Qualitative Disclosures About Market Risk

 

 Not applicable.

 

Item 4 – Controls and Procedures

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting, as defined in Exchange Act Rules 13a-15(f) and 15d-15(f), is a process designed by, or under the supervision of, our principal executive and principal financial officers and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP and includes those policies and procedures that:

 

  pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

 

  provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

 

  provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our consolidated financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Management conducted an evaluation of the effectiveness of internal control over financial reporting for the twelve months ended December 31, 2023 based on criteria established in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). In connection with this evaluation, management identified a deficiency that constituted a material weakness in our internal control over financial reporting as of December 31, 2023, pertaining to income tax accounting. For more information on this deficiency, see Item 9A. Controls and Procedures, included in our Annual Report on Form 10-K. Based on management’s evaluation of internal control over financial reporting for the twelve months ended December 31, 2023, and as of September 30, 2024, our disclosure controls and procedures were not effective as of September 30, 2024 due to the aforementioned material weakness pertaining to income tax accounting.

 

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim consolidated financial statements will not be prevented or detected on a timely basis.

 

The Company has begun to develop new controls designed to remediate the aforementioned 2023 material weakness pertaining to income tax accounting, which the Company intends to implement during 2024.

 

Changes in Internal Control Over Financial Reporting

 

During the quarter ended September 30, 2024, we continued to implement the following changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting as follows: (a) we replaced the Company’s outside tax accounting and tax return preparer with a new firm (the “Tax Accounting Firm”); (b) we retained the Tax Accounting Firm (i) to prepare the Company’s income tax accounting and disclosures for the quarter ended September 30, 2024 and (ii) to review the income tax accounting and disclosures prepared by the predecessor firm for the quarter ended March 31, 2024 prior to the filing of the Form 10-Q for the quarter ended March 31, 2024; (c) we updated our financial risk assessment to reflect tax accounting as a high risk area, and (d) we adopted a tax accounting review checklist provided by our Sarbanes-Oxley consulting firm for use by CPI’s finance management in reviewing the quarterly and annual work of the Tax Accounting Firm, beginning with the tax accounting for the quarter ended June 30, 2024.

 

18

 

 

Part II - Other Information

 

Item 1 – Legal Proceedings

 

None.

 

Item 1A – Risk Factors

 

“Item 1A. Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2023, includes a discussion of significant factors known to us that could materially adversely affect our business, financial condition, or results of operations. There have been no material changes from the risk factors disclosed in the Annual Report.

 

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3 – Defaults Upon Senior Securities

 

None.

 

Item 4 – Mine Safety Disclosures

 

Not applicable.

 

Item 5 – Other Information

 

None.

 

Item 6 – Exhibits

 

Exhibit No. Description
31.1* Section 302 Certification by Chief Executive Officer and President
31.2* Section 302 Certification by Chief Financial Officer (Principal Accounting Officer)
32.1** Section 906 Certification by Chief Executive Officer and Chief Financial Officer
101.INS** Inline XBRL Instance Document. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH* Inline XBRL Taxonomy Extension Schema Document.
101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB* Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104** Cover Page Interactive Data File. The cover page XBRL tags are embedded within the Inline XBRL document.

 

* Filed herewith  

** Furnished herewith

 

Attached as Exhibit 101 to this report are the following formatted in Inline XBRL (Extensible Business Reporting Language): (i) Condensed Consolidated Statement of Operations for the three and nine months ended September 30, 2024 and 2023, (ii) Condensed Consolidated Balance Sheet as of September 30, 2024 and December 31, 2023, (iii) Condensed Consolidated Statement of Cash Flows for the nine months ended September 30, 2024 and 2023, (iv) Condensed Consolidated Statement of Changes in Equity for the three and nine months ended September 30, 2024 and 2023 and (v) Notes to Condensed Consolidated Financial Statements.

 

19

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  CPI AEROSTRUCTURES, INC.
     
Dated: November 13, 2024 By. /s/ Dorith Hakim
    Dorith Hakim
   

Chief Executive Officer and President  

(Principal Executive Officer)   

     
Dated: November 13, 2024 By. /s/ Philip Passarello
    Philip Passarello
   

Chief Financial Officer  

(Principal Financial and Accounting Officer)   

 

20

 

CPI AEROSTRUCTURES, INC. 10-Q

EXHIBIT 31.1

 

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Dorith Hakim, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of CPI Aerostructures, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and to the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: November 13, 2024 CPI AEROSTRUCTURES, INC.
  (Registrant)
     
  By: /s/ Dorith Hakim
    Dorith Hakim
    Chief Executive Officer, President and Director
    (Principal Executive Officer)

 

 

 

 

CPI AEROSTRUCTURES, INC. 10-Q

EXHIBIT 31.2

 

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Philip Passarello, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of CPI Aerostructures, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and to the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: November 13, 2024 CPI AEROSTRUCTURES, INC.
  (Registrant)
     
  By: /s/ Philip Passarello
    Philip Passarello
    Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

 

 

 

CPI AEROSTRUCTURES, INC. 10-Q

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of CPI Aerostructures, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2024 as filed with the Securities and Exchange Commission (the “Report”), the undersigned, in the capacities and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Dated: November 13, 2024 CPI AEROSTRUCTURES, INC.
  (Registrant)
   
  By: /s/ Dorith Hakim
    Dorith Hakim
    Chief Executive Officer, President and Director
    (Principal executive officer)
     
Dated: November 13, 2024 CPI AEROSTRUCTURES, INC.
  (Registrant)
   
  By: /s/ Philip Passarello
    Philip Passarello
    Chief Financial Officer and Secretary
    (Principal financial and accounting officer)

 

 

 

v3.24.3
Cover - shares
9 Months Ended
Sep. 30, 2024
Nov. 12, 2024
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2024  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --12-31  
Entity File Number 1-11398  
Entity Registrant Name CPI AEROSTRUCTURES, INC.  
Entity Central Index Key 0000889348  
Entity Tax Identification Number 11-2520310  
Entity Incorporation, State or Country Code NY  
Entity Address, Address Line One 91 Heartland Blvd.  
Entity Address, City or Town Edgewood  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 11717  
City Area Code (631)  
Local Phone Number 586-5200  
Title of 12(b) Security Common stock, $0.001 par value per share  
Trading Symbol CVU  
Security Exchange Name NYSEAMER  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   13,000,670
v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Current Assets:    
Cash $ 1,708,987 $ 5,094,794
Accounts receivable, net of allowance for credit losses 6,574,853 4,352,196
Contract assets, net 33,618,971 35,312,068
Inventory 1,052,286 1,436,647
Refundable income taxes 40,000 40,000
Prepaid expenses and other current assets 377,858 678,026
Total Current Assets 43,372,955 46,913,731
Operating lease right-of-use assets 3,334,992 4,740,193
Property and equipment, net 819,078 794,056
Deferred tax asset 19,425,407 19,938,124
Goodwill 1,784,254 1,784,254
Other assets 151,077 189,774
Total Assets 68,887,763 74,360,132
Current Liabilities:    
Accounts payable 14,994,451 10,487,012
Accrued expenses 5,742,854 10,275,695
Contract liabilities 1,390,127 5,937,629
Loss reserve 24,888 337,351
Current portion of line of credit 2,730,000 2,400,000
Current portion of long-term debt 31,330 44,498
Operating lease liabilities, current 2,118,329 1,999,058
Income taxes payable 28,748 30,107
Total Current Liabilities 27,060,727 31,511,350
Line of credit, net of current portion 15,390,000 17,640,000
Long-term operating lease liabilities 1,494,942 3,100,571
Long-term debt, net of current portion 2,734 26,483
Total Liabilities 43,948,403 52,278,404
Commitments and Contingencies (see note 11)
Shareholders’ Equity:    
Common stock - $.001 par value; authorized 50,000,000 shares, 12,933,408 and 12,771,434 shares, respectively, issued and outstanding 12,933 12,771
Additional paid-in capital 74,402,288 73,872,679
Accumulated deficit (49,475,861) (51,803,722)
Total Shareholders’ Equity 24,939,360 22,081,728
Total Liabilities and Shareholders’ Equity $ 68,887,763 $ 74,360,132
v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Sep. 30, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, authorized 50,000,000 50,000,000
Common stock, issued 12,933,408 12,771,434
Common stock, outstanding 12,933,408 12,771,434
v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Revenue $ 19,419,879 $ 20,399,369 $ 59,311,356 $ 62,963,592
Cost of sales 15,200,210 16,693,279 46,422,514 49,990,986
Gross profit 4,219,669 3,706,090 12,888,842 12,972,606
Selling, general and administrative expenses 2,742,036 2,535,065 8,231,875 8,210,603
Income from operations 1,477,633 1,171,025 4,656,967 4,762,003
Interest expense (573,366) (663,857) (1,793,472) (1,816,408)
Income before provision for income taxes 904,267 507,168 2,863,495 2,945,595
Provision for income taxes 154,590 205,804 535,634 503,850
Net income $ 749,677 $ 301,364 $ 2,327,861 $ 2,441,745
Income per common share, basic $ 0.06 $ 0.02 $ 0.19 $ 0.19
Income per common share, diluted $ 0.06 $ 0.02 $ 0.18 $ 0.19
Shares used in computing income per common share:        
  Basic 12,647,023 12,759,971 12,559,876 12,613,899
  Diluted 12,717,128 12,793,133 12,650,340 12,647,061
v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2022 $ 12,507 $ 73,189,449 $ (69,004,926) $ 4,197,030
Beginning balance (in shares) at Dec. 31, 2022 12,506,795      
Net income 983,305 983,305
Issuance of common stock upon settlement of restricted stock, net $ 19 19
Issuance of common stock upon settlement of restricted stock, net (in shares) 19,247      
Stock-based compensation expense 338,904 338,904
Ending balance, value at Mar. 31, 2023 $ 12,526 73,528,353 (68,021,621) 5,519,258
Ending balance (in shares) at Mar. 31, 2023 12,526,042      
Beginning balance, value at Dec. 31, 2022 $ 12,507 73,189,449 (69,004,926) 4,197,030
Beginning balance (in shares) at Dec. 31, 2022 12,506,795      
Net income       2,441,745
Ending balance, value at Sep. 30, 2023 $ 12,761 73,849,050 (66,563,181) 7,298,630
Ending balance (in shares) at Sep. 30, 2023 12,760,331      
Beginning balance, value at Mar. 31, 2023 $ 12,526 73,528,353 (68,021,621) 5,519,258
Beginning balance (in shares) at Mar. 31, 2023 12,526,042      
Net income 1,157,076 1,157,076
Issuance of common stock upon settlement of restricted stock, net $ 201 201
Issuance of common stock upon settlement of restricted stock, net (in shares) 201,125      
Stock-based compensation expense 180,015 180,015
Ending balance, value at Jun. 30, 2023 $ 12,727 73,708,368 (66,864,545) 6,856,550
Ending balance (in shares) at Jun. 30, 2023 12,727,167      
Net income 301,364 301,364
Issuance of common stock upon settlement of restricted stock, net $ 34 34
Issuance of common stock upon settlement of restricted stock, net (in shares) 33,164      
Stock-based compensation expense 140,682 140,682
Ending balance, value at Sep. 30, 2023 $ 12,761 73,849,050 (66,563,181) 7,298,630
Ending balance (in shares) at Sep. 30, 2023 12,760,331      
Beginning balance, value at Dec. 31, 2023 $ 12,771 73,872,679 (51,803,722) $ 22,081,728
Beginning balance (in shares) at Dec. 31, 2023 12,771,434     12,771,434
Net income 168,238 $ 168,238
Issuance of common stock upon settlement of restricted stock, net $ 13 13
Issuance of common stock upon settlement of restricted stock, net (in shares) 13,334      
Stock-based compensation expense 281,510 281,510
Ending balance, value at Mar. 31, 2024 $ 12,784 74,154,189 (51,635,484) 22,531,489
Ending balance (in shares) at Mar. 31, 2024 12,784,768      
Beginning balance, value at Dec. 31, 2023 $ 12,771 73,872,679 (51,803,722) $ 22,081,728
Beginning balance (in shares) at Dec. 31, 2023 12,771,434     12,771,434
Net income       $ 2,327,861
Ending balance, value at Sep. 30, 2024 $ 12,933 74,402,288 (49,475,861) $ 24,939,360
Ending balance (in shares) at Sep. 30, 2024 12,933,408     12,933,408
Beginning balance, value at Mar. 31, 2024 $ 12,784 74,154,189 (51,635,484) $ 22,531,489
Beginning balance (in shares) at Mar. 31, 2024 12,784,768      
Net income 1,409,946 1,409,946
Issuance of common stock upon settlement of restricted stock, net $ 179 179
Issuance of common stock upon settlement of restricted stock, net (in shares) 178,095      
Stock-based compensation expense 175,356 175,356
Ending balance, value at Jun. 30, 2024 $ 12,963 74,329,545 (50,225,538) 24,116,970
Ending balance (in shares) at Jun. 30, 2024 12,962,863      
Net income 749,677 749,677
Issuance of common stock upon settlement of restricted stock, net $ (30) (30)
Issuance of common stock upon settlement of restricted stock, net (in shares) (29,455)      
Stock-based compensation expense 72,743 72,743
Ending balance, value at Sep. 30, 2024 $ 12,933 $ 74,402,288 $ (49,475,861) $ 24,939,360
Ending balance (in shares) at Sep. 30, 2024 12,933,408     12,933,408
v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income $ 2,327,861 $ 2,441,745
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Depreciation and amortization 305,260 350,974
Amortization of debt issuance cost 38,697 81,024
Stock-based compensation 529,771 659,855
Deferred income taxes 512,717 500,220
Provision for credit losses 144,565
Amortization of operating lease right-of-use assets 1,405,201 1,330,209
Changes in operating assets and liabilities:    
Increase in accounts receivable (2,367,222) (4,266,415)
Decrease in insurance receivable 3,600,000
Decrease (increase) in contract assets 1,693,097 (3,646,028)
Decrease in inventory 384,361 842,196
Decrease in prepaid expenses and other assets 300,168 305,526
Increase in accounts payable and accrued expenses 236,130 3,093,351
(Decrease) increase in contract liabilities (4,547,502) 667,615
Decrease in settlement of litigation obligation (3,600,000)
Decrease in operating lease liabilities (1,486,359) (1,320,706)
Decrease in loss reserve (312,463) (204,916)
(Decrease) increase in income taxes payable (1,359) 5,478
Net cash (used in) provided by operating activities (837,077) 840,128
Cash flows from investing activities:    
Purchase of property and equipment (330,282) (92,954)
Net cash used in investing activities (330,282) (92,954)
Cash flows from financing activities:    
Principal payments on line of credit (1,920,000)
Principal payments on long-term debt (36,917) (1,930,372)
Repayments of insurance financing obligation (261,531)
Debt issuance costs paid (54,334)
Net cash used in financing activities (2,218,448) (1,984,706)
Net decrease in cash (3,385,807) (1,237,532)
Cash at beginning of period 5,094,794 3,847,225
Cash at end of period 1,708,987 2,609,693
Cash paid during the period for:    
Interest 1,795,495 1,815,939
Income taxes $ 36,457
v3.24.3
INTERIM FINANCIAL STATEMENTS
9 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
INTERIM FINANCIAL STATEMENTS

 

  1. INTERIM FINANCIAL STATEMENTS

 

Basis of Presentation

 

The Company consists of CPI Aerostructures, Inc. (“CPI Aero”), Welding Metallurgy, Inc. (“WMI”), a wholly owned subsidiary of CPI Aero, and Compac Development Corporation, a wholly owned subsidiary of WMI (collectively, the “Company”, “we”, “us”, or “our”).

 

The condensed consolidated interim financial statements of the Company as of September 30, 2024 and for the three and nine months ended September 30, 2024 and 2023 have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and notes normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to those rules and regulations. The consolidated balance sheet at December 31, 2023 has been derived from audited consolidated financial statements, but does not include all of the information and notes required by U.S. GAAP. The Company believes that the disclosures are adequate to make the information presented not misleading.

 

All adjustments that, in the opinion of the management, are necessary for a fair presentation for the periods presented have been reflected. Such adjustments are of a normal, recurring nature. It is suggested that these consolidated financial statements be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the “Form 10-K”). The results of operations for interim periods are not necessarily indicative of the operating results to be expected for the full year or any other interim period.

 

An operating segment, in part, is a component of an enterprise whose operating results are regularly reviewed by the chief operating decision maker (the “CODM”) to make decisions about resources to be allocated to the segment and assess its performance. Operating segments may be aggregated only to a limited extent. The Company’s CODM, the Chief Executive Officer, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance. The Company has determined that it has a single operating and reportable segment.

 

The Company maintains its cash in multiple financial institutions. The balances are insured by the Federal Deposit Insurance Corporation. From time to time, the Company’s balances may exceed insurance limits. As of September 30, 2024, the Company had $1,476,844 of uninsured balances. The Company limits its credit risk by selecting financial institutions considered to be highly creditworthy.

 

Recently Issued Accounting Standards – Not Adopted

 

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which focuses on the rate reconciliation and income taxes paid. ASU No. 2023-09 requires a public business entity (“PBE”) to disclose, on an annual basis, a tabular rate reconciliation using both percentages and currency amounts, broken out into specified categories with certain reconciling items further broken out by nature and jurisdiction to the extent those items exceed a specified threshold. In addition, all entities are required to disclose income taxes paid, net of refunds received disaggregated by federal, state/local, and foreign and by jurisdiction if the amount is at least 5% of total income tax payments, net of refunds received. For PBEs, the new standard is effective for annual periods beginning after December 15, 2024, with early adoption permitted. An entity may apply the amendments in this ASU prospectively by providing the revised disclosures for the period ending December 31, 2025 and continuing to provide the pre-ASU disclosures for the prior periods, or may apply the amendments retrospectively by providing the revised disclosures for all period presented. We expect this ASU to only impact our disclosures with no impacts to our results of operations, cash flows, and financial condition.

 

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which focuses on a PBE to disclose entity-wide and segment information in the notes to financial statements. This includes the measure of profit or loss that the CODM uses to assess segment performance and decide how to allocate resources, as well as certain specified amounts included in that measure – e.g. revenue, depreciation and amortization, interest and income tax expense. For PBEs, the new standard is effective for annual periods beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. We expect this ASU to only impact our disclosures with no impacts to our results of operations, cash flows, and financial condition.

v3.24.3
REVENUE
9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
REVENUE

  2. REVENUE

 

Disaggregation of Revenue

 

The following tables present the Company’s revenue disaggregated by contract type and revenue recognition method:

 

    Three months ended
September 30,
    Nine months ended
September 30,
 
    2024     2023     2024     2023  
Government subcontracts   $ 16,986,106     $ 15,375,337     $ 48,951,748     $ 50,550,256  
                                 
Prime government contracts     1,673,483       3,943,723       7,056,711       8,062,682  
Commercial contracts     760,290       1,080,309       3,302,897       4,350,654  
    $ 19,419,879     $ 20,399,369     $ 59,311,356     $ 62,963,592  

 

    Three months ended
September 30,
    Nine months ended
September 30,
 
    2024     2023     2024     2023  
Revenue recognized using over time revenue recognition model   $ 19,092,000     $ 20,053,771     $ 58,558,552     $ 59,353,845  
                                 
Revenue recognized using point in time revenue recognition model     327,879       345,598       752,804       3,609,747  
    $ 19,419,879     $ 20,399,369     $ 59,311,356     $ 62,963,592  

 

Favorable/(Unfavorable) Adjustments to Gross Profit

 

We review our Estimates at Completion (“EAC”) at least quarterly. Due to the nature of the work required to be performed on many of the Company’s performance obligations, the estimation of total revenue and cost at completion is complex, subject to many inputs, and requires significant judgment by management on a contract-by-contract basis. As part of this process, management reviews information including, but not limited to, any outstanding key contract matters, progress towards completion and the related program schedule, identified risks and opportunities, and the related changes in estimates of revenues and costs. The risks and opportunities relate to management’s judgment about the ability and cost to achieve the schedule, consideration of customer-directed delays or reductions in scheduled deliveries, technical requirements, customer activity levels, and related variable consideration. Management must make assumptions and estimates regarding contract revenue and costs, including estimates of labor productivity and availability, the complexity and scope of the work to be performed, the availability and cost of materials including any impact from changing costs or inflation, the length of time to complete the performance obligation, the availability and timing of funding from our customer, and overhead cost rates, among others.

 

Changes in estimates of net sales, cost of sales, and the related impact to operating profit on contracts recognized over time are recognized on a cumulative catch-up basis, which recognizes the cumulative effect of the profit changes on current and prior periods based on a performance obligation’s percentage-of-completion in the current period. A significant change in one or more of these estimates could affect the profitability of one or more of our performance obligations. Our EAC adjustments also include the establishment of, and changes to, loss provisions for our contracts accounted for on a percentage-of-completion basis.

 

Net EAC adjustments had the following impact on our gross profit during the nine months ended September 30, 2024 and 2023:

 

    Nine months ended  
    September 30,
2024
    September 30,
2023
 
Favorable adjustments   $ 1,835,489     $ 2,383,071  
Unfavorable adjustments     (4,059,160 )     (3,396,171 )
Net adjustments   $ (2,223,671 )   $ (1,013,100 )

 

 

Transaction Price Allocated to Remaining Performance Obligations

 

As of September 30, 2024, the aggregate amount of transaction price allocated to the remaining performance obligations was approximately $91.5 million. This represents the amount of revenue the Company expects to recognize in the future on contracts with unsatisfied or partially satisfied performance obligations as of September 30, 2024.

v3.24.3
CONTRACT ASSETS AND LIABILITIES
9 Months Ended
Sep. 30, 2024
Contract Assets And Liabilities  
CONTRACT ASSETS AND LIABILITIES

3. CONTRACT ASSETS AND LIABILITIES

 

Contract assets represent revenue recognized on contracts in excess of amounts invoiced to the customers and the Company’s right to consideration is conditional on something other than the passage of time. Amounts may not exceed their net realizable value. Under the typical payment terms of our government as well as military contractor contracts, the customer retains a portion of the contract price until completion of the contract, as a measure of protection for the customer. Our government and military contract or contracts therefore typically result in revenue recognized in excess of billings, which we present as contract assets. Contract assets are classified as current assets. The Company’s contract liabilities represent customer payments received or due from the customer in excess of revenue recognized. Contract liabilities are classified as current liabilities.

 

   

September 30,

2024  

   

December 31,

2023 

 
Contract assets   $ 33,618,971     $ 35,312,068  
Contract liabilities     1,390,127       5,937,629  

 

Revenue recognized for the nine months ended September 30, 2024 and 2023 that was included in the contract liabilities balance as of January 1, 2024 and 2023, respectively, was approximately $5.0 million and $3.0 million, respectively.

v3.24.3
INVENTORY
9 Months Ended
Sep. 30, 2024
Inventory Disclosure [Abstract]  
INVENTORY

4. INVENTORY

 

The components of inventory consisted of the following:

 

   

September 30, 

2024 

   

December 31,

2023 

 
Raw materials   $ 440,016     $ 648,264  
Work in progress     103,390       75,795  
Finished goods     508,880       712,588  
Inventory   $ 1,052,286     $ 1,436,647  

  

v3.24.3
STOCK-BASED COMPENSATION
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION

5. STOCK-BASED COMPENSATION

 

In 2009, the Company adopted the Performance Equity Plan 2009 (the “2009 Plan”). The 2009 Plan reserved 500,000 common shares for issuance. The 2009 Plan provides for the issuance of either incentive stock options or nonqualified stock options to employees, consultants or others who provide services to the Company. The Company has 2,364 shares available for grant under the 2009 Plan as of September 30, 2024.

 

In 2016, the Company adopted the 2016 Long Term Incentive Plan (the “2016 Plan”). The 2016 Plan reserved 600,000 common shares for issuance, provided that no more than 200,000 common shares be granted as incentive stock options. Awards may be made or granted to employees, officers, directors and consultants in the form of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units and other stock-based awards. Any shares of common stock granted in connection with awards other than stock options and stock appreciation rights are counted against the number of shares reserved for issuance under the 2016 Plan as one and one-half shares of common stock for every one share of common stock granted in connection with such award. Any shares of common stock granted in connection with stock options and stock appreciation rights are counted against the number of shares reserved for issuance under the 2016 Plan as one share for every one share of common stock issuable upon the exercise of such stock option or stock appreciation right awarded. In the fourth quarter of 2020, the Company added 800,000 shares to the 2016 Plan, which increased the number of shares reserved for issuance under the 2016 Plan to 1,400,000 shares. In the second quarter of 2023, the Company added an additional 800,000 shares to the 2016 Plan, which increased the number of shares for reserved for issuance under the 2016 Plan to 2,200,000 shares. The Company has 376,094 shares available for grant under the 2016 Plan as of September 30, 2024.

 

Stock-based compensation expense for restricted stock in the consolidated statements of operations is summarized as follows:

                             
    Three months ended
September 30,
    Nine months ended
September 30,
 
    2024     2023     2024     2023  
Cost of sales   $ 14,430     $ 6,612     $ 3,675     $ 58,860  
Selling, general and administrative     58,283       134,104       526,096       600,995  
 Total stock-based compensation expense   $ 72,713     $ 140,716     $ 529,771     $ 659,855  

 

The Company grants restricted stock units (“RSUs”) to its board of directors as partial compensation. These RSUs vest quarterly on a straight-line basis over a one-year period and will fully vest on October 1, 2024.

 

The following table summarizes activity related to outstanding RSUs for the nine months ended September 30, 2024:

 

    RSUs    

Weighted Average  

Grant Date  

Fair Value of  

RSUs 

 
Non-vested – January 1, 2024         $  
Granted     181,323     $ 2.45  
Vested     (135,900 )   $ 2.45  
Forfeited         $  
Non-vested – September 30, 2024     45,423     $ 2.45  

 

The Company grants shares of common stock (“Restricted Stock Awards” or “RSAs”) to select employees. These shares have various vesting dates, ranging from vesting on the grant date to as late as four years from the date of grant. In the event that the employee’s employment is voluntarily terminated prior to certain vesting dates, portions of the shares may be forfeited. At September 30, 2024, the weighted average remaining amortization period was 2.7 years.

 

The following table summarizes activity related to outstanding Restricted Stock Awards for the nine months ended September 30, 2024:

 

   

Restricted 

Stock Awards 

   

Weighted Average   

Grant Date 

Fair Value of  

Restricted
Stock Awards 

 
Non-vested – January 1, 2024     167,071     $ 3.25  
Granted     107,604     $ 2.39  
Vested     (58,587 )   $ 3.18  
Forfeited     (63,213 )   $ 2.78  
Non-vested – September 30, 2024     152,875     $ 2.86  

 

The Company grants shares of common stock (“Performance Restricted Stock Awards” or “PRSAs”) to select officers as part of our long-term incentive program that will result in that number of PRSAs being paid out if the target performance metric is achieved. The award vesting is based on specific performance metrics related to accounts payable delinquency, debt, and net income during the performance period. The PRSAs vest at 0% or 100% and all three metrics must be met to vest at 100%. The PRSAs granted under this program will vest on the fourth anniversary of the grant date, subject to the aforementioned performance criteria. At September 30, 2024, the weighted average remaining amortization period was 2.6 years.

 

The following table summarizes activity related to outstanding PRSAs for the nine months ended September 30, 2024:

 

    PRSAs    

Weighted
Average Grant Date  

Fair Value of  

PRSAs  

 
Non-vested – January 1, 2024     48,050     $ 3.27  
Granted     64,611     $ 2.91  
Vested         $  
Forfeited     (68,585 )   $ 3.12  
Non-vested – September 30, 2024     44,076     $ 2.98  

 

The fair value of all RSUs, PRSAs and RSAs is based on the closing price of our common stock on the grant date. All RSUs, PRSAs, and Restricted Stock Awards vest and settle in common stock (on a one-for-one basis).

 

As of September 30, 2024, unamortized stock-based compensation costs related to restricted share arrangements was $284,780.

v3.24.3
NET INCOME PER SHARE
9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
NET INCOME PER SHARE

6. NET INCOME PER SHARE

 

Basic and diluted income per common share is computed using the weighted average number of common shares outstanding. Diluted income per common share is adjusted for the incremental shares attributed to unvested RSUs and RSAs. Incremental shares of 70,105 and 90,463 were used in the calculation of diluted income per common share for the three and nine months ended September 30, 2024, respectively. Incremental shares of 33,162 were used in the calculation of diluted income per common share for both the three and nine months ended September 30, 2023.

v3.24.3
LINE OF CREDIT AND LONG-TERM DEBT
9 Months Ended
Sep. 30, 2024
Debt Disclosure [Abstract]  
LINE OF CREDIT AND LONG-TERM DEBT

7. LINE OF CREDIT AND LONG-TERM DEBT

 

On March 24, 2016, the Company entered into the Amended and Restated Credit Agreement with the lenders named therein and BankUnited N.A. as Sole Arranger, Agent and Collateral Agent (as amended from time to time, the “Credit Agreement” or the “BankUnited Facility”). The BankUnited Facility originally provided for a revolving credit loan commitment of $30 million (the “Revolving Loan”) and a $10 million term loan (“Term Loan”). The Revolving Loan bears interest at a rate based upon a pricing grid, as defined in the Credit Agreement. 

 

On February 20, 2024, the Company entered into a Thirteenth Amendment to the Credit Agreement (the “Thirteenth Amendment”). Under the Thirteenth Amendment, the parties amended the Credit Agreement by (a) extending the maturity date of the Company’s existing revolving line of credit to August 31, 2025; and (b) setting the aggregate maximum principal amount of all revolving line of credit loans to $19,800,000 from January 1, 2024 through March 31, 2024, $19,080,000 from April 1, 2024 through June 30, 2024, $18,360,000 from July 1, 2024 through September 30, 2024, $17,640,000 from October 1, 2024 through December 31, 2024, $16,920,000 from January 1, 2025 through March 31, 2025, $16,200,000 from April 1, 2025 through June 30, 2025 and $15,480,000 from July 1, 2025 onward, and for payments to be made by the Company to comply therewith (if any such payments are necessary), on the first day of each such period. 

 

On November 13, 2024, the Company entered into a Fourteenth Amendment to the Credit Agreement (the “Fourteenth Amendment”). Under the Fourteenth Amendment, the parties amended the Credit Agreement by: (i) extending the maturity date of the Company’s existing revolving line of credit (the “Revolving Credit Loans”) to August 31, 2026; (ii) reducing the Base Rate Margin (as defined in the Credit Agreement) from 3.50% to 2.0%; (iii) resetting the aggregate maximum principal amount of all Revolving Credit Loans to $16,890,000 from January 1, 2025 through March 31, 2025, $16,140,000 from April 1, 2025 through June 30, 2025, $15,390,000 from July 1, 2025 through September 30, 2025, $14,640,000 from October 1, 2025 through December 31, 2025, $13,890,000 from January 1, 2026 through March 31, 2026, $13,140,000 from April 1, 2026 through June 30, 2026, and $12,390,000 from July 1, 2026 onward and for payments to be made by the Company to comply therewith (if any such payments are necessary), on the first day of each such period; and (iv) requiring the Company, if it does not deliver to BankUnited, N.A. by December 31, 2025, a commitment letter with banks and terms and conditions reasonably acceptable to the Lenders for refinancing the obligations under the Credit Agreement, to make a payment by January 31, 2026, equal to 2% of the aggregate outstanding principal amount of the Revolving Credit Loans as of December 31, 2025, with 50% of such payment applied to reduce the aggregate outstanding principal and the remaining 50% retained by the Lenders as an amendment fee with respect to the Fourteenth Amendment.

 

The Credit Agreement, as amended, requires us to maintain the following financial covenants: (a) minimum debt service coverage ratio of no less than 1.5 to 1.0 for trailing four fiscal quarter periods; (b) maximum leverage ratio of no less than 4.0 to 1.0 for trailing four fiscal quarter periods; (c) minimum net income after taxes as of the end of each fiscal quarter being no less than $1.00; and (d) a minimum adjusted EBITDA at the end of each fiscal quarter of no less than $1.0 million. The additional principal payments, increase in interest and the Amendment Fee provided for in the Eighth Amendment (entered into on October 28, 2021) and Ninth Amendment to the Credit Agreement (entered into on April 12, 2022) are excluded for purposes of calculating compliance with each of the financial covenants.

 

The BankUnited Facility is secured by all of the Company’s assets. Prior to the Fourteenth Amendment, the Revolving Loan bore interest at the Prime Rate + 3.50%. The Prime Rate was 8.0% as of September 30, 2024 and as such, the Company’s interest rate on the Revolving Loan was 11.5% as of September 30, 2024.

 

As of September 30, 2024 and December 31, 2023, the Company had $18,120,000 and $20,040,000 outstanding under the Revolving Loan, respectively. $2,730,000 of the Revolving Loan is payable by September 30, 2025 and the remaining balance of $15,390,000 of the revolving line of credit matures and is payable by August 31, 2026, as amended November 13, 2024. 

 

The Company has cumulatively paid approximately $962,000 of total debt issuance costs in connection with the BankUnited Facility, of which approximately $43,000 and $82,000 is unamortized and is included in other assets at September 30, 2024 and December 31, 2023, respectively. 

 

Also included in long-term debt are financing leases of $34,064 and $70,981 at September 30, 2024 and December 31, 2023, respectively, including a current portion of $31,330 and $44,498, respectively. The maturities of the September 30, 2024 balance of these financing leases are as follows:

 

For the Year Ending December 31,    
Remainder of 2024   $ 7,581  
2025     26,483  
Total                      $ 34,064  

v3.24.3
MAJOR CUSTOMERS AND VENDORS
9 Months Ended
Sep. 30, 2024
Risks and Uncertainties [Abstract]  
MAJOR CUSTOMERS AND VENDORS

 

8. MAJOR CUSTOMERS AND VENDORS
   

During the nine months ended September 30, 2024, our four largest customers accounted for 35%, 24%, 12%, and 12% of revenue. During the nine months ended September 30, 2023, our four largest customers accounted for 31%, 26%, 12% and 10% of revenue. During the three months ended September 30, 2024, our three largest customers accounted for 40%, 23% and 11% of revenue. During the three months ended September 30, 2023, our four largest customers accounted for 28%, 21%, 19% and 13% of revenue.

 

At September 30, 2024, 38%, 25%, and 13% of our accounts receivable were from three of our largest customers. At December 31, 2023, 30%, 17%, 12%, and 11% of accounts receivable were due from our four largest customers. 

 

At September 30, 2024, 27%, 26%, 15% and 12% of our contract assets were from four of our largest customers. At December 31, 2023, 26%, 23%, 18%, and 15% of our contract assets were related to our four largest customers.

 

At September 30, 2024, 10% of our accounts payable was from one of our largest vendors. At December 31, 2023 no vendors accounted for 10% of our accounts payable.

v3.24.3
LEASES
9 Months Ended
Sep. 30, 2024
Leases  
LEASES

 

 9. LEASES

 

The Company leases manufacturing and office space under an agreement classified as an operating lease. On November 10, 2021, the Company executed the second amendment to the lease agreement for its manufacturing and office space, which extends the lease agreement’s expiration date to April 30, 2026. The lease agreement does not include any renewal options. The agreement provides for an initial monthly base amount plus annual escalations through the term of the lease. In addition to the monthly base amounts in the lease agreement, the Company is required to pay real estate taxes and operating expenses during the lease terms.

 

The Company also leases office equipment in agreements classified as operating leases.  

 

For the nine months ended September 30, 2024 and 2023, the Company’s operating lease expense was $1,611,487 and $1,612,713, respectively. For the three months ended September 30, 2024 and 2023, the Company’s operating lease expense was $528,127 and $529,624, respectively.

 

Future minimum lease payments under non-cancellable operating leases as of September 30, 2024 were as follows:

 

For the Year Ending December 31,        
Remainder of 2024     $ 560,249  
2025       2,283,354  
2026       850,276  
2027       111,065  
2028       9,228  
Total undiscounted operating lease payments       3,814,172  
Less imputed interest       (200,901 )
Present value of operating lease payments     $ 3,613,271  

 

The following table sets forth the right-of-use assets and operating lease liabilities as of: 

 

    September 30,
2024
    December 31,
2023
 
Assets                
Right-of-use assets, net   $ 3,334,992     $ 4,740,193  
                 
Liabilities                
Current operating lease liabilities   $ 2,118,329     $ 1,999,058  
Long-term operating lease liabilities     1,494,942       3,100,571  
Total lease liabilities   $ 3,613,271     $ 5,099,629  

 

The Company’s weighted average remaining lease term for its operating leases is 1.7 years as of September 30, 2024. The Company’s weighted average discount rate for its operating leases is 5.5% as of September 30, 2024.

v3.24.3
INCOME TAXES
9 Months Ended
Sep. 30, 2024
Income Tax Disclosure [Abstract]  
INCOME TAXES
10. INCOME TAXES

 

Income taxes are accounted for under the asset and liability method whereby deferred tax assets and liabilities are recognized for future tax consequences attributable to the temporary differences between the consolidated financial statements carrying amounts of assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company’s policy is to record estimated interest and penalties related to uncertain tax positions in income tax expense. 

 

The provision for income tax for the three months ended September 30, 2024 and 2023 was $154,590 and $205,804, respectively. The provision for income tax for the nine months ended September 30, 2024 and 2023 was $535,634 and $503,850, respectively.

 

The effective income tax rate for the nine months ended September 30, 2024 is 18.7 %. The difference between the effective income tax rate for the nine months ended September 30, 2024 and the statutory income tax rate of 21.0% for the nine months ended September 30, 2024 is due primarily to the estimated R&D credit, state income taxes and permanent tax differences. The effective income tax rate for the nine months ended September 30, 2023 was 17.1%. The difference between the effective income tax rate for the nine months ended September 30, 2023 and the statutory income tax rate of 21% for the nine months ended September 30, 2023 was due to the estimated R&D credit, the partial release of approximately $122,500 of the Company’s valuation allowance on its deferred tax asset recorded during the nine months ending September 30, 2023, state income taxes and permanent tax differences.

v3.24.3
COMMITMENTS AND CONTINGENCIES
9 Months Ended
Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

11. COMMITMENTS AND CONTINGENCIES

 

The Company may be involved in various claims, suits, assessments, investigations, and legal proceedings that arise from time to time in the ordinary course of its business. The Company accrues a liability when it is both probable a liability has been incurred and the amount of the loss can be reasonably estimated. The Company reviews these accruals at least quarterly and adjusts them to reflect ongoing negotiations, settlements, rulings, advice of legal counsel, and other relevant information. To the extent new information is obtained and the Company’s views on the probable outcomes of claims, suits, assessments, investigations, or legal proceedings change, changes in the Company’s accrued liabilities would be recorded in the period such determination is made. For some matters, the amount of liability is not probable or the amount cannot be reasonably estimated and, therefore, accruals have not been made.

 

The Company reached a settlement with the SEC on June 20, 2024 related to the Company’s previously announced and filed restatements of certain of its financial statements for fiscal periods between January 1, 2018 and December 31, 2022. Under the terms of this settlement, if the Company fails to comply with various undertakings, a civil monetary penalty in the amount of $400,000 will be due to the SEC by June 30, 2025 (the “Undertakings”). The Undertakings are as follows: (a) the Company shall fully remediate its outstanding material weaknesses in Internal Controls over Financial Reporting (“ICFR”) and have effective ICFR and disclosure controls and procedures (“DCP”) by December 31, 2024; (b) the Company shall publicly disclose, concurrent with the filing of the 2024 Form 10-K, whether in management’s opinion, the Company has fully remediated its material weaknesses in ICFR and has effective ICFR and DCP; and (c) the Company shall certify, in writing, compliance with the undertaking(s) set forth above. The certification shall be made by the Company’s CEO and identify the undertaking(s), provide written evidence of compliance in the form of a narrative, and be supported by exhibits sufficient to demonstrate compliance. The certification and supporting material shall be submitted to the SEC no later than sixty (60) days from the date of the completion of the undertakings.

v3.24.3
INTERIM FINANCIAL STATEMENTS (Policies)
9 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The Company consists of CPI Aerostructures, Inc. (“CPI Aero”), Welding Metallurgy, Inc. (“WMI”), a wholly owned subsidiary of CPI Aero, and Compac Development Corporation, a wholly owned subsidiary of WMI (collectively, the “Company”, “we”, “us”, or “our”).

 

The condensed consolidated interim financial statements of the Company as of September 30, 2024 and for the three and nine months ended September 30, 2024 and 2023 have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and notes normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to those rules and regulations. The consolidated balance sheet at December 31, 2023 has been derived from audited consolidated financial statements, but does not include all of the information and notes required by U.S. GAAP. The Company believes that the disclosures are adequate to make the information presented not misleading.

 

All adjustments that, in the opinion of the management, are necessary for a fair presentation for the periods presented have been reflected. Such adjustments are of a normal, recurring nature. It is suggested that these consolidated financial statements be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the “Form 10-K”). The results of operations for interim periods are not necessarily indicative of the operating results to be expected for the full year or any other interim period.

 

An operating segment, in part, is a component of an enterprise whose operating results are regularly reviewed by the chief operating decision maker (the “CODM”) to make decisions about resources to be allocated to the segment and assess its performance. Operating segments may be aggregated only to a limited extent. The Company’s CODM, the Chief Executive Officer, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance. The Company has determined that it has a single operating and reportable segment.

 

The Company maintains its cash in multiple financial institutions. The balances are insured by the Federal Deposit Insurance Corporation. From time to time, the Company’s balances may exceed insurance limits. As of September 30, 2024, the Company had $1,476,844 of uninsured balances. The Company limits its credit risk by selecting financial institutions considered to be highly creditworthy.

Recently Issued Accounting Standards – Not Adopted

Recently Issued Accounting Standards – Not Adopted

 

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which focuses on the rate reconciliation and income taxes paid. ASU No. 2023-09 requires a public business entity (“PBE”) to disclose, on an annual basis, a tabular rate reconciliation using both percentages and currency amounts, broken out into specified categories with certain reconciling items further broken out by nature and jurisdiction to the extent those items exceed a specified threshold. In addition, all entities are required to disclose income taxes paid, net of refunds received disaggregated by federal, state/local, and foreign and by jurisdiction if the amount is at least 5% of total income tax payments, net of refunds received. For PBEs, the new standard is effective for annual periods beginning after December 15, 2024, with early adoption permitted. An entity may apply the amendments in this ASU prospectively by providing the revised disclosures for the period ending December 31, 2025 and continuing to provide the pre-ASU disclosures for the prior periods, or may apply the amendments retrospectively by providing the revised disclosures for all period presented. We expect this ASU to only impact our disclosures with no impacts to our results of operations, cash flows, and financial condition.

 

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which focuses on a PBE to disclose entity-wide and segment information in the notes to financial statements. This includes the measure of profit or loss that the CODM uses to assess segment performance and decide how to allocate resources, as well as certain specified amounts included in that measure – e.g. revenue, depreciation and amortization, interest and income tax expense. For PBEs, the new standard is effective for annual periods beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. We expect this ASU to only impact our disclosures with no impacts to our results of operations, cash flows, and financial condition.

v3.24.3
REVENUE (Tables)
9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
The following tables present the Company’s revenue disaggregated by contract type and revenue recognition method:

The following tables present the Company’s revenue disaggregated by contract type and revenue recognition method:

 

    Three months ended
September 30,
    Nine months ended
September 30,
 
    2024     2023     2024     2023  
Government subcontracts   $ 16,986,106     $ 15,375,337     $ 48,951,748     $ 50,550,256  
                                 
Prime government contracts     1,673,483       3,943,723       7,056,711       8,062,682  
Commercial contracts     760,290       1,080,309       3,302,897       4,350,654  
    $ 19,419,879     $ 20,399,369     $ 59,311,356     $ 62,963,592  

 

    Three months ended
September 30,
    Nine months ended
September 30,
 
    2024     2023     2024     2023  
Revenue recognized using over time revenue recognition model   $ 19,092,000     $ 20,053,771     $ 58,558,552     $ 59,353,845  
                                 
Revenue recognized using point in time revenue recognition model     327,879       345,598       752,804       3,609,747  
    $ 19,419,879     $ 20,399,369     $ 59,311,356     $ 62,963,592  
Net EAC adjustments had the following impact on our gross profit during the nine months ended September 30, 2024 and 2023:

Net EAC adjustments had the following impact on our gross profit during the nine months ended September 30, 2024 and 2023:

 

    Nine months ended  
    September 30,
2024
    September 30,
2023
 
Favorable adjustments   $ 1,835,489     $ 2,383,071  
Unfavorable adjustments     (4,059,160 )     (3,396,171 )
Net adjustments   $ (2,223,671 )   $ (1,013,100 )
v3.24.3
CONTRACT ASSETS AND LIABILITIES (Tables)
9 Months Ended
Sep. 30, 2024
Contract Assets And Liabilities  
Schedule of contract assets and liabilities

 

   

September 30,

2024  

   

December 31,

2023 

 
Contract assets   $ 33,618,971     $ 35,312,068  
Contract liabilities     1,390,127       5,937,629  
v3.24.3
INVENTORY (Tables)
9 Months Ended
Sep. 30, 2024
Inventory Disclosure [Abstract]  
The components of inventory consisted of the following:

The components of inventory consisted of the following:

 

   

September 30, 

2024 

   

December 31,

2023 

 
Raw materials   $ 440,016     $ 648,264  
Work in progress     103,390       75,795  
Finished goods     508,880       712,588  
Inventory   $ 1,052,286     $ 1,436,647  
v3.24.3
STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-based compensation expense for restricted stock in the consolidated statements of operations is summarized as follows:

Stock-based compensation expense for restricted stock in the consolidated statements of operations is summarized as follows:

                             
    Three months ended
September 30,
    Nine months ended
September 30,
 
    2024     2023     2024     2023  
Cost of sales   $ 14,430     $ 6,612     $ 3,675     $ 58,860  
Selling, general and administrative     58,283       134,104       526,096       600,995  
 Total stock-based compensation expense   $ 72,713     $ 140,716     $ 529,771     $ 659,855  
The following table summarizes activity related to outstanding RSUs for the nine months ended September 30, 2024:

The following table summarizes activity related to outstanding RSUs for the nine months ended September 30, 2024:

 

    RSUs    

Weighted Average  

Grant Date  

Fair Value of  

RSUs 

 
Non-vested – January 1, 2024         $  
Granted     181,323     $ 2.45  
Vested     (135,900 )   $ 2.45  
Forfeited         $  
Non-vested – September 30, 2024     45,423     $ 2.45  
The following table summarizes activity related to outstanding Restricted Stock Awards for the nine months ended September 30, 2024:

The following table summarizes activity related to outstanding Restricted Stock Awards for the nine months ended September 30, 2024:

 

   

Restricted 

Stock Awards 

   

Weighted Average   

Grant Date 

Fair Value of  

Restricted
Stock Awards 

 
Non-vested – January 1, 2024     167,071     $ 3.25  
Granted     107,604     $ 2.39  
Vested     (58,587 )   $ 3.18  
Forfeited     (63,213 )   $ 2.78  
Non-vested – September 30, 2024     152,875     $ 2.86  
The following table summarizes activity related to outstanding PRSAs for the nine months ended September 30, 2024:

The following table summarizes activity related to outstanding PRSAs for the nine months ended September 30, 2024:

 

    PRSAs    

Weighted
Average Grant Date  

Fair Value of  

PRSAs  

 
Non-vested – January 1, 2024     48,050     $ 3.27  
Granted     64,611     $ 2.91  
Vested         $  
Forfeited     (68,585 )   $ 3.12  
Non-vested – September 30, 2024     44,076     $ 2.98  
v3.24.3
LINE OF CREDIT AND LONG-TERM DEBT (Tables)
9 Months Ended
Sep. 30, 2024
Debt Disclosure [Abstract]  
The maturities of the September 30, 2024 balance of these financing leases are as follows:

Also included in long-term debt are financing leases of $34,064 and $70,981 at September 30, 2024 and December 31, 2023, respectively, including a current portion of $31,330 and $44,498, respectively. The maturities of the September 30, 2024 balance of these financing leases are as follows:

 

For the Year Ending December 31,    
Remainder of 2024   $ 7,581  
2025     26,483  
Total                      $ 34,064  
v3.24.3
LEASES (Tables)
9 Months Ended
Sep. 30, 2024
Leases  
Future minimum lease payments under non-cancellable operating leases as of September 30, 2024 were as follows:

Future minimum lease payments under non-cancellable operating leases as of September 30, 2024 were as follows:

 

For the Year Ending December 31,        
Remainder of 2024     $ 560,249  
2025       2,283,354  
2026       850,276  
2027       111,065  
2028       9,228  
Total undiscounted operating lease payments       3,814,172  
Less imputed interest       (200,901 )
Present value of operating lease payments     $ 3,613,271  
The following table sets forth the right-of-use assets and operating lease liabilities as of:

The following table sets forth the right-of-use assets and operating lease liabilities as of: 

 

    September 30,
2024
    December 31,
2023
 
Assets                
Right-of-use assets, net   $ 3,334,992     $ 4,740,193  
                 
Liabilities                
Current operating lease liabilities   $ 2,118,329     $ 1,999,058  
Long-term operating lease liabilities     1,494,942       3,100,571  
Total lease liabilities   $ 3,613,271     $ 5,099,629  
v3.24.3
INTERIM FINANCIAL STATEMENTS (Details Narrative)
Sep. 30, 2024
USD ($)
Accounting Policies [Abstract]  
Uninsured balance $ 1,476,844
v3.24.3
The following tables present the Company’s revenue disaggregated by contract type and revenue recognition method: (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Disaggregation of Revenue [Line Items]        
Revenue $ 19,419,879 $ 20,399,369 $ 59,311,356 $ 62,963,592
Transferred over Time [Member]        
Disaggregation of Revenue [Line Items]        
Revenue 19,092,000 20,053,771 58,558,552 59,353,845
Transferred at Point in Time [Member]        
Disaggregation of Revenue [Line Items]        
Revenue 327,879 345,598 752,804 3,609,747
Government subcontracts [Member]        
Disaggregation of Revenue [Line Items]        
Revenue 16,986,106 15,375,337 48,951,748 50,550,256
Prime government contracts [Member]        
Disaggregation of Revenue [Line Items]        
Revenue 1,673,483 3,943,723 7,056,711 8,062,682
Commercial contracts [Member]        
Disaggregation of Revenue [Line Items]        
Revenue $ 760,290 $ 1,080,309 $ 3,302,897 $ 4,350,654
v3.24.3
Net EAC adjustments had the following impact on our gross profit during the nine months ended September 30, 2024 and 2023: (Details) - USD ($)
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Net adjustments $ (2,223,671) $ (1,013,100)
Favorable adjustments [Member]    
Net adjustments 1,835,489 2,383,071
Unfavorable adjustments [Member]    
Net adjustments $ (4,059,160) $ (3,396,171)
v3.24.3
REVENUE (Details Narrative)
$ in Millions
Sep. 30, 2024
USD ($)
Revenue from Contract with Customer [Abstract]  
Remaining performance obligations $ 91.5
v3.24.3
Schedule of Contract liabilities are classified as current liabilities (Details) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Contract Assets And Liabilities    
Contract assets $ 33,618,971 $ 35,312,068
Contract liabilities $ 1,390,127 $ 5,937,629
v3.24.3
CONTRACT ASSETS AND LIABILITIES (Details Narrative) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Contract Assets And Liabilities    
Revenue recognized that was included in contract liabilities $ 5.0 $ 3.0
v3.24.3
The components of inventory consisted of the following: (Details) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Raw materials $ 440,016 $ 648,264
Work in progress 103,390 75,795
Finished goods 508,880 712,588
Inventory $ 1,052,286 $ 1,436,647
v3.24.3
Stock-based compensation expense for restricted stock in the consolidated statements of operations is summarized as follows: (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
 Total stock-based compensation expense $ 72,713 $ 140,716 $ 529,771 $ 659,855
Cost of Sales [Member]        
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
 Total stock-based compensation expense 14,430 6,612 3,675 58,860
Selling, General and Administrative Expenses [Member]        
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
 Total stock-based compensation expense $ 58,283 $ 134,104 $ 526,096 $ 600,995
v3.24.3
The following table summarizes activity related to outstanding RSUs for the nine months ended September 30, 2024: (Details) - Restricted Stock Units (RSUs) [Member]
9 Months Ended
Sep. 30, 2024
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Non vested January 1, 2024 | shares
Non vested January 1, 2024 | $ / shares
Granted | shares 181,323
Granted | $ / shares $ 2.45
Vested | shares (135,900)
Vested | $ / shares $ 2.45
Forfeited | shares
Forfeited | $ / shares
Non vested September 30, 2024 | shares 45,423
Non vested September 30, 2024 | $ / shares $ 2.45
v3.24.3
The following table summarizes activity related to outstanding Restricted Stock Awards for the nine months ended September 30, 2024: (Details) - Restricted Stock [Member]
9 Months Ended
Sep. 30, 2024
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Non vested January 1, 2024 | shares 167,071
Non vested January 1, 2024 | $ / shares $ 3.25
Granted | shares 107,604
Granted | $ / shares $ 2.39
Vested | shares (58,587)
Vested | $ / shares $ 3.18
Forfeited | shares (63,213)
Forfeited | $ / shares $ 2.78
Non vested September 30, 2024 | shares 152,875
Non vested September 30, 2024 | $ / shares $ 2.86
v3.24.3
The following table summarizes activity related to outstanding PRSAs for the nine months ended September 30, 2024: (Details) - Performance Shares [Member]
9 Months Ended
Sep. 30, 2024
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Non vested January 1, 2024 | shares 48,050
Non vested January 1, 2024 | $ / shares $ 3.27
Granted | shares 64,611
Granted | $ / shares $ 2.91
Vested | shares
Vested | $ / shares
Forfeited | shares (68,585)
Forfeited | $ / shares $ 3.12
Non vested September 30, 2024 | shares 44,076
Non vested September 30, 2024 | $ / shares $ 2.98
v3.24.3
STOCK-BASED COMPENSATION (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2023
Dec. 31, 2020
Sep. 30, 2024
Dec. 31, 2016
Dec. 31, 2009
Restricted Stock Units (RSUs) [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Vesting period     1 year    
RSUs fully vest date     Oct. 01, 2024    
Restricted Stock [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Weighted average remaining amortization period     2 years 8 months 12 days    
Restricted Stock [Member] | Maximum [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Vesting period     4 years    
Performance Shares [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Weighted average remaining amortization period     2 years 7 months 6 days    
Unamortized stock-based compensation costs     $ 284,780    
Performance Shares [Member] | Share-Based Payment Arrangement, Tranche One [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Vesting percentage     0.00%    
Performance Shares [Member] | Share-Based Payment Arrangement, Tranche Two [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Vesting percentage     100.00%    
Performance Equity Plan 2009 [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Shares reserved for issuance         500,000
Shares available for grant     2,364    
Long Term Incentive Plan 2016 [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Shares reserved for issuance 2,200,000 1,400,000   600,000  
Shares available for grant     376,094    
Increase in number of shares reserved for issuance 800,000 800,000      
Long Term Incentive Plan 2016 [Member] | Share-Based Payment Arrangement, Option [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Shares reserved for issuance       200,000  
v3.24.3
NET INCOME PER SHARE (Details Narrative) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Earnings Per Share [Abstract]        
Incremental shares used in calculation of diluted income per common share 70,105 33,162 90,463 33,162
v3.24.3
The maturities of the September 30, 2024 balance of these financing leases are as follows: (Details)
Sep. 30, 2024
USD ($)
Debt Disclosure [Abstract]  
Remainder of 2024 $ 7,581
2025 26,483
Total                    $ 34,064
v3.24.3
LINE OF CREDIT AND LONG-TERM DEBT (Details Narrative)
9 Months Ended
Nov. 13, 2024
USD ($)
Feb. 20, 2024
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Mar. 24, 2016
USD ($)
Line of Credit Facility [Line Items]            
Prime rate     8.00%      
Current portion of line of credit     $ 2,730,000   $ 2,400,000  
Line of credit     15,390,000   17,640,000  
Payments of debt issuance costs     $ 54,334    
Financing leases     34,064   70,981  
Financing leases current     $ 31,330   44,498  
Bank United [Member]            
Line of Credit Facility [Line Items]            
Minimum debt service coverage ratio     1.5      
Maximum leverage ratio     4.0      
Minimum adjusted EBITDA     $ 1,000,000.0      
Payments of debt issuance costs     962,000      
Debt issuance costs     43,000   82,000  
Bank United [Member] | Minimum [Member]            
Line of Credit Facility [Line Items]            
Net income required under agreement     1.00      
Bank United [Member] | Revolving Credit Facility [Member]            
Line of Credit Facility [Line Items]            
Line of credit facility, maximum borrowing capacity           $ 30,000,000
Expiration date   Aug. 31, 2025        
Outstanding loans     18,120,000   $ 20,040,000  
Current portion of line of credit     2,730,000      
Line of credit     $ 15,390,000      
Bank United [Member] | Revolving Credit Facility [Member] | Subsequent Event [Member]            
Line of Credit Facility [Line Items]            
Expiration date Aug. 31, 2026          
Bank United [Member] | Revolving Credit Facility [Member] | Period One [Member]            
Line of Credit Facility [Line Items]            
Line of credit facility, maximum borrowing capacity   $ 19,800,000        
Bank United [Member] | Revolving Credit Facility [Member] | Period One [Member] | Subsequent Event [Member]            
Line of Credit Facility [Line Items]            
Line of credit facility, maximum borrowing capacity $ 16,890,000          
Bank United [Member] | Revolving Credit Facility [Member] | Period Two [Member]            
Line of Credit Facility [Line Items]            
Line of credit facility, maximum borrowing capacity   19,080,000        
Bank United [Member] | Revolving Credit Facility [Member] | Period Two [Member] | Subsequent Event [Member]            
Line of Credit Facility [Line Items]            
Line of credit facility, maximum borrowing capacity 16,140,000          
Bank United [Member] | Revolving Credit Facility [Member] | Period Three [Member]            
Line of Credit Facility [Line Items]            
Line of credit facility, maximum borrowing capacity   18,360,000        
Bank United [Member] | Revolving Credit Facility [Member] | Period Three [Member] | Subsequent Event [Member]            
Line of Credit Facility [Line Items]            
Line of credit facility, maximum borrowing capacity 15,390,000          
Bank United [Member] | Revolving Credit Facility [Member] | Period Four [Member]            
Line of Credit Facility [Line Items]            
Line of credit facility, maximum borrowing capacity   17,640,000        
Bank United [Member] | Revolving Credit Facility [Member] | Period Four [Member] | Subsequent Event [Member]            
Line of Credit Facility [Line Items]            
Line of credit facility, maximum borrowing capacity 14,640,000          
Bank United [Member] | Revolving Credit Facility [Member] | Period Five [Member]            
Line of Credit Facility [Line Items]            
Line of credit facility, maximum borrowing capacity   16,920,000        
Bank United [Member] | Revolving Credit Facility [Member] | Period Five [Member] | Subsequent Event [Member]            
Line of Credit Facility [Line Items]            
Line of credit facility, maximum borrowing capacity 13,890,000          
Bank United [Member] | Revolving Credit Facility [Member] | Period Six [Member]            
Line of Credit Facility [Line Items]            
Line of credit facility, maximum borrowing capacity   16,200,000        
Bank United [Member] | Revolving Credit Facility [Member] | Period Six [Member] | Subsequent Event [Member]            
Line of Credit Facility [Line Items]            
Line of credit facility, maximum borrowing capacity 13,140,000          
Bank United [Member] | Revolving Credit Facility [Member] | Period Seven [Member]            
Line of Credit Facility [Line Items]            
Line of credit facility, maximum borrowing capacity   $ 15,480,000        
Bank United [Member] | Revolving Credit Facility [Member] | Period Seven [Member] | Subsequent Event [Member]            
Line of Credit Facility [Line Items]            
Line of credit facility, maximum borrowing capacity $ 12,390,000          
Bank United [Member] | Term loan [Member]            
Line of Credit Facility [Line Items]            
Debt instrument, face amount           $ 10,000,000
Bank United [Member] | Revolving Loan [Member]            
Line of Credit Facility [Line Items]            
Prime rate Plus     3.50%      
Interest rate     11.50%      
Bank United [Member] | Revolving Loan [Member] | Subsequent Event [Member]            
Line of Credit Facility [Line Items]            
Prime rate Plus 2.00%          
Payment percentage of outstanding principal amount of revolving line of credit loans 2.00%          
Payment percentage applied to outstanding principal 50.00%          
Payment percentage retained by lenders as amendment fee 50.00%          
v3.24.3
MAJOR CUSTOMERS AND VENDORS (Details Narrative) - Customer Concentration Risk [Member]
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Revenue Benchmark [Member] | Customer One [Member]          
Concentration Risk [Line Items]          
Concentration Risk, Percentage 40.00% 28.00% 35.00% 31.00%  
Revenue Benchmark [Member] | Customer Two [Member]          
Concentration Risk [Line Items]          
Concentration Risk, Percentage 23.00% 21.00% 24.00% 26.00%  
Revenue Benchmark [Member] | Customer Three [Member]          
Concentration Risk [Line Items]          
Concentration Risk, Percentage 11.00% 19.00% 12.00% 12.00%  
Revenue Benchmark [Member] | Customer Four [Member]          
Concentration Risk [Line Items]          
Concentration Risk, Percentage   13.00% 12.00% 10.00%  
Accounts Receivable [Member] | Customer One [Member]          
Concentration Risk [Line Items]          
Concentration Risk, Percentage     38.00%   30.00%
Accounts Receivable [Member] | Customer Two [Member]          
Concentration Risk [Line Items]          
Concentration Risk, Percentage     25.00%   17.00%
Accounts Receivable [Member] | Customer Three [Member]          
Concentration Risk [Line Items]          
Concentration Risk, Percentage     13.00%   12.00%
Accounts Receivable [Member] | Customer Four [Member]          
Concentration Risk [Line Items]          
Concentration Risk, Percentage         11.00%
Contract Assets [Member] | Customer One [Member]          
Concentration Risk [Line Items]          
Concentration Risk, Percentage     27.00%   26.00%
Contract Assets [Member] | Customer Two [Member]          
Concentration Risk [Line Items]          
Concentration Risk, Percentage     26.00%   23.00%
Contract Assets [Member] | Customer Three [Member]          
Concentration Risk [Line Items]          
Concentration Risk, Percentage     15.00%   18.00%
Contract Assets [Member] | Customer Four [Member]          
Concentration Risk [Line Items]          
Concentration Risk, Percentage     12.00%   15.00%
Accounts Payable [Member] | Vendor One [Member]          
Concentration Risk [Line Items]          
Concentration Risk, Percentage     10.00%    
v3.24.3
Future minimum lease payments under non-cancellable operating leases as of September 30, 2024 were as follows: (Details) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Leases    
Remainder of 2024 $ 560,249  
2025 2,283,354  
2026 850,276  
2027 111,065  
2028 9,228  
Total undiscounted operating lease payments 3,814,172  
Less imputed interest (200,901)  
Present value of operating lease payments $ 3,613,271 $ 5,099,629
v3.24.3
The following table sets forth the right-of-use assets and operating lease liabilities as of: (Details) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Assets    
Right-of-use assets, net $ 3,334,992 $ 4,740,193
Liabilities    
Current operating lease liabilities 2,118,329 1,999,058
Long-term operating lease liabilities 1,494,942 3,100,571
Total lease liabilities $ 3,613,271 $ 5,099,629
v3.24.3
LEASES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Leases        
Expiration date     Apr. 30, 2026  
Operating lease expense $ 528,127 $ 529,624 $ 1,611,487 $ 1,612,713
Weighted average remaining lease term operating leases 1 year 8 months 12 days   1 year 8 months 12 days  
Weighted average discount rate for its operating leases 5.50%   5.50%  
v3.24.3
INCOME TAXES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Tax Disclosure [Abstract]        
Provision for income taxes $ 154,590 $ 205,804 $ 535,634 $ 503,850
Effective income tax rate     18.70% 17.10%
Statutory income tax rate     21.00% 21.00%
Valuation allowance released       $ 122,500
v3.24.3
COMMITMENTS AND CONTINGENCIES (Details Narrative)
1 Months Ended
Jun. 20, 2024
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Settlement amount $ 400,000

CPI Aerostructures (AMEX:CVU)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024 CPI Aerostructures 차트를 더 보려면 여기를 클릭.
CPI Aerostructures (AMEX:CVU)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024 CPI Aerostructures 차트를 더 보려면 여기를 클릭.